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Abstract 
The focus of this research was to develop a route to S ,6-fused 1-aza-2-
oxobicycloalkane amino acids, beta-tum peptidomimetics, with carbon-based 
bridgehead substituents. The route that was developed proceeded as follows: 
Geminal acylation of the acetal derived from hex-5-en-2-one gave 2-(3-butenyl)-
2-methyl-1 ,3-cyclopentanedione in 76% yield. Experiments with baker's yeast 
showed that desymmetricization of this 1,3-diketone could be carried out with 
very high enantioselectivity. Beckman rearrangement of (2S, 3S) 2-(3-butenyl)-3-
[(tert-butyldimethylsilyl)oxy ]-2-methylcyclopentanone using 0-
mesitylenesulfonyl hydroxylamine provided the corresponding lactam, (3S, 4S)-
l-Aza-6-(3-butenyl)-S-[(tert-butyldimethylsilyl)oxy ]~· methyl-2-cyclohexanone. 
·cyclization of the lactam nitrogen onto the double bond was carried out with 
trimethylsilyl triflate and iodine i_n the presence of triethylamine which yielded the 
iodolactam {6S,SS,9S)-l-aza-5-[(tert-butyldimethylsilyl)oxy ]-9-(iodomethyl)-6-
methyl- bicyclo[4.3.0]nonan-2-one. This iodolactam was then converted into the 
propyl ester of (6S,5S,9S)-1-aza-S-[(tert-butyldimethylsilyl)oxy ]-9-
(hydroxymethyl)-6-methylbicyclo[ 4.3.0]nonan-2-one. The development of this 
route, including the elucidation of the structures of side-products, is discussed in 
detail. 
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Introduction 
Geminal acylation involves the replacement of the carbonyl moiety of a 
ketone or aldehyde directly, or via their acetals by two acyl groups. Kuwajima 
and co-workers' reported that an acetal or an aldehyde with 1,2-
bis[(trimethylsilyl}oxy]cyclobutene 1 yielded a cyclobutanone derivative l under 
Lewis acid catalysis (Scheme 1). The transformation of the cyclobutanone 
intermediate l to the desired diketone 3 could be achieved by excess 
trifluoroacetic acid (TF A), p-toluenesulfonic acid (p-TsOH) in hot benzene, 
BF3•E~O, or trimethylsilyl triflate {TMS-OTt). 
Scheme 1 
Lewis Acid 
I 
0 
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2 
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Kuwajima and co-workers1 first introduced this methodology as a two-step 
procedure that involved isolation of cyclobutanone intermediate 2 (Scheme 1 ). 
1 
TiC14 was found to be the optimal Lewis acid to use for aldehydes and aliphatic 
acetals, however BF3·E~O was the reagent of choice for the more reactive acetals. 
The mechanism for the formation of the geminal acylation products is 
shown in Scheme 2. The initial step in the geminal acylation reaction is a 
Mukaiyama-like aldol reaction that gives a cyclobutanone compound. The second 
step is an acid-initiated acyl migration similar to a pinacol rearrangement to 
provide a 1 ,3-diketone. 
Schemel 
.. 
• 
1 
TMS 
xo 0 ~ 
e, 
F]ll 
Kuwajima also reported several instances in which the cyclobutanone ring 
underwent acid-catalyzed cleavage to furnish a y-keto-ester such as 4 (Scheme 3). 
This process, called reductive succinoylation, was observed with a number of 
2 
Lewis acids but could be accomplished in a single step using SnCI...1 It was found 
that the facility of ring cleavage was related to the structure of the substrate. 
Scheme3 
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Several modifications to the original Kuwajima procedure have since been 
reported. Wu and Bumell2 found that this reaction could be effected in a single 
step, usually in higher yield, by using two to three molar equivalents of 1 and a 
large excess ofBF3•E~O (Scheme 4). The cyclobutanone intermediate was not 
isolated since in the presence of excess Lewis acid, the acyl migration readily 
occurs. 
3 
Seheme4 
10 eq. BF3•Et10 
(96%) 
In addition, Wu and Bumell3 illustrated that the geminal acylation was 
applicable using 1,2-bis[(trimethylsily)oxy]cyclopentene 5 to produce the six 
membered 1,3-diketone 6 as shown in SchemeS. 
Scheme 5 
n 
0 0 
6 
Kuwajima stated that ketones are unreactive under the conditions of the 
initial aldol step1, and that the one-pot procedure was not successful using 
ketones.4 However, Jenkins and Bumell4 reported an efficient synthesis of2,2-
disubstituted 1,3-cyclopentanediones by using 1.5 equivalents of I with an 
equivalent amount of BF3•Et20. A small volume of water, approximately 
4 
equivalent to the volume ofBF3·E~O, was required, followed by a large excess of 
BF3·E~O. It was believed that the addition of water and acid must have helped 
the rearrangement by hydrolyzing of one or both of the (trimethylsilyl)oxy groups 
of7 (Scheme 6). An obvious advantage of this modification was the reduction in 
the number of synthetic steps required to generate the desired 1 ,3-diketone 
moiety. 
Scbeme6 
7 
l.HaO 
2. BF3•Et20 
(94°/e) 
• 
Crane and Bumell5 improved the geminal acylation reaction for aromatic 
ketones such as 8 (Scheme 7) and «,~-unsaturated ketones. The geminal acylation 
of saturated ketones required the addition of water for the formation of 1,3-
cyclopentanediones in good yield. However, aromatic and «,~-unsaturated 
ketones underwent this step readily under anhydrous conditions. This was 
attributed to aUyliclbenzylic stabilization of a positive charge in the transition 
state of the rearrangement. 
5 
Scheme7 
0 
0 
8 
Geminal acylation reactions have also been reported for methyl-substituted 
analogues of 1~-bis[(trimethylsilyl)oxy]cyclobutene (9).6 BC13 is the preferred 
Lewis acid instead ofBF3·E~O when using compound 9 as shown in Scheme 8. 
BF3·E~O facilitates an equilibration processes involving the aldol product- the 
cyclobutanone intermediate - which leads to the production of furanone by-
products. The mechanism of action for BCI3 is different, in that it inhibits the 
equilibration after initiating the initial aldol reaction, thereby resulting in 
improved yields of the desired diketone substrate. 
Seheme8 
0 
BCI3 
(98%) 
6 
The geminal acylation reaction is a powerful carbon-carbon forming 
reaction. The creation of a spirocyclic center can be a cballenging process for the 
synthetic organic chemist since such a center is necessarily sterically congested. 
Consequently, this reaction has gained synthetic utility for the synthesis of natural 
products (Figure 1 ). Wu and Burnell2 synthesized isokhusimone, 10, which is a 
derivative of the zizaane sesquiterpenes and may serve as common intermediate 
for all such sesquiterpenes. 
Ogasawera and co-workers7 synthesized (-)-chokel G II, a fungitoxic 
metaoolite from the stromata of Epichloetyphia. Cephalotaxine, 11 has also been 
synthesized by a strategy employing geminal acylation methodology. 1 This 
compound is of interest since several members of this family exhibit anti-cancer 
properties. 
Wu and Burnell9 once again utilized geminal acylation methodology to 
yield (±)-epi-pentalenene, 13, and (±)-pentalenene, 14. Pentalenene is the 
biosynthetic precursor to the antibiotic sesquiterpenoid pentalenolactone. 
The geminal acylation reaction was also a key step in the synthesis of P-
bulnesene, 1510 and for the introduction of the unusual spirodiketone functionality 
present in ftedericamycin A, 16.11 Compound 16 is of considerable interest 
because of its antitumor properties. 
7 
Figure 1: Natural products synthesized utilizing geminal acylation methodology 
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Another potential use of the geminal acylation reaction is for the 
production of mimics for the turn regions present in naturally occurring peptides. 
During the past two decades there has been considerable interest in the rational 
design and production of highly active analogues of naturally occurring 
biologically active peptides.12. 13 It is believed that such compounds could result in 
pharmaceuticals with enhanced selectivity and, as a result, reduced toxicity 
compared to the medications currently used. 
Naturally occurring small linear peptides show biological activity as 
hormones, neurotransmitters, neuromodulators and immunologically-active 
peptides. As a result, these peptides are of great interest to the medicinal chemist. 
Small peptides are commonly used as initial lead compounds. However several 
limitations exist for these native peptides and this restricts their application as 
potential pharmaceuticals. Such limitations include14: 
1. Rapid metabolism by proteolysis in the gastrointestinal tract, in the blood and 
in the numerous tissue beds. 
2. Poor transport from the gastrointestinal tract to the blood and from the blood to 
the brain. 
3. Rapid excretion by the liver and kidneys. 
4. Lack of specificity of activity due to the conformational flexibility inherent to 
peptides. 
S. Uncertainty about the relation between three-dimensional structure and activity. 
Thus, the motivation for the development of peptide mimics 
9 
(peptidomimetics) is to overcome the aforementioned limitations. A generally 
applicable and successful method for the development of peptidomimetics has 
been the production of conformationally restricted analogues. Conformational 
restrictions enable such peptides to have improved metabolic stability since they 
are more resistant toward proteases. 
Two important factors should be considered 1s in the design of 
peptidomimetics as potential bioactive substances. F~ a complimentary fit 
must take place between the desired peptidomimetic and the receptor. Secon~ the 
placement of certain structural elements such as functional groups, polar regions 
and hydrophobic regions must be in positions that favor interactions like hydrogen 
bonding, electrostatic interactions and hydrophobic interactions. 
a-Helices, P-sheets and reverse turns are secondary structures of peptides 
that arise as a result of intramolecular hydrogen bonding. All have been targeted 
in the design of mimics, however most of the focus has centered on the reverse 
turns. Many of the twns in proteins are located on the surface of the protein. 
Thus, the surface locations and the predominance of residues containing 
potentially important pbarmacophoric information has led to the hypothesis that 
turns play critical roles in numerous recognition events.16•17 
Two types of turns exist, the u-tum and the P-tum. The P-tum consists of 
a four-amino-acid residue sequence in which the peptide chain reverses direction, 
by approximately 180°.11 In the P-tum structure, the carbonyl of the first amino 
acid residue is aligned to form an intra-chain hydrogen bond with the amide 
10 
hydrogen of the fourth amino acid resid~ and this forms a pseudo-ten membered 
ring17 (Figure 2). P-Turns that do not exhibit hydrogen bonding are called open 
turns. However, about 6()0.4 of P·tums commonly found show an intramolecular 
hydrogen bond.11 The ex-tum structure is a three-amino-acid residue reverse tum. 
a-Turns are not as widespread as P-tums. In «·turns, the carbonyl of the first 
amino acid residue is aligned to form an intra--chain hydrogen bond with the 
amide hydrogen of the third amino acid residue, which then results in a pseudo-
seven membered ring. The pseudo.cyclic systems can have different puckered 
conformations depending upon the orientation of the amide bonds and side chains 
on the residues making up the tum.17 Th~e side chains can then help with 
receptor recognition if the exposed functional groups of the amino acid residues 
allow a favorable fit. 
Figure 217• Classical view of a P·tum 
AmiaoAcid l Amiao Acid 3 
AIDiaoAcid 1 
Turns can be described by the distance from the c. of the first amino acid residue 
11 
to the c. of the fourth amino acid residue, and when this distance is less than 7 A 
and the tetrapeptide sequence is not in an u helical region it is considered to be a 
~tum. 16 The most widely accepted system for the classification of P-turns is 
based upon the peptide backbone torsion angles of the second and third amino 
acids. 11 The predicted ideal torsion angles are given in Table 1, although they are 
rarely observed in proteins. 
Table 1. Torsion angles (degrees) for classical P-turns 
Tum type 
Torsion 
Angle I I' II II' m m· 
(Fig. 2) 
1 .60 60 .60 60 -60 60 
2 -30 30 120 120 -30 30 
3 -90 90 80 80 -60 60 
4 0 0 0 0 -30 30 
To prepare conformationally restricted analogues~ reverse tum mimics are 
generally cyclic or bicyclic dipeptides. Many of these molecules feature the 1-
azabicyclo[X Y.O]alkane skeleton19 (Figure 3) . This basic ring system can also 
encompass heteroatom analogues in which a carbon is replaced by sulfur, oxygen, 
or nitrogen, although these sometimes have the disadvantage of reduced stability 
12 
under acidic conditions. In addition, any one of the methylene carbons in this 5,6-
fused bicyclic system can have various substituents. All of the compounds that 
have been reported in the literature have R = H (Figure 3), so the production of 
analogues with R ~ H is a fertile area for investigation. 
Figure 3. Azabicyclo[X Y. O]alkane amino acid skeleton 
C~H 
Compounds with this azabicyclo[X Y.O]alkane amino acid skeleton have 
proved useful as ~-tum mimics. Many others are still known only as potential P-
tum mimics, based on conformational analysis. 
Lubell and coworkersl0 synthesized 17a and 18a and found by 
conformational analysis that both have torsion angles similar to the second and 
third amino acid residues of an ideal type n· ~-tum confonnation. These have yet 
to be incorporated into peptides to explore their actual ability to induce a reverse 
tum. Compounds 19 and 20 also possess the azabicyclo[X Y.O]alkane amino acid 
skeleton except that one of the methylene carbons is replaced by an oxygen.21 No 
comment was made on their potential use or the ability of these to induce a 
reverse tum. 
13 
Scolastico and coworkers22 synthesized 17b and 18b and found that their 
ability to act as reverse tum inducers was dependant on the stereocbemisty at the 
bridgehead carbon. The isomers 17b and 18b were suggested to be potential 
reverse tum inducers based on conformational analysis, but their incorporation 
into real peptide chains was not performed. Colombo and co-workersD reported a 
stereoselective synthesis of compound ll, and it was determined from molecular 
mechanics calculations that it also has the potential to invoke a reverse tum. 
17a R-H 
17b R-Me 
lQ 
llaR=H 
llbR""'Me 19 
PKH~ Ac~~N~ 1 
0 ~Ba 
ll 
Compounds ll and 23 were designed and synthesized by Hanessian and 
coworkersl4 as potential antagonists for the NK-2 receptor of the tachykinins. The 
physiological significance oftachykinins is still poorly understood, because of the 
absence of selective antagonists. The receptors for substance P and for 
neurokinins A and Bare designated NK-1, NK.-2, and NK.-3, respectively. The 
14 
effects of substance P have been examined the most and it has been found that it 
triggers contraction of the smooth muscles of the respiratory, gastrointestinal, and 
urogenital tracts. In addition, substance P is a potent stimulator for the secretion 
of saliva, pancreatic juice, and bile. Neurokinin A has effects similar to those of 
substance P, but ne~kinin 8 operates as a pain reliever by the release of ligands 
ofthe opiate receptor.ll 
Antagonists for the NK-l and NK-3 receptors are known, but the NK-2 
receptor has been somewhat more elusive. It was determined that 2l bas no 
affinity for the NK-l receptor, but it does have a low affinity for the NK.-2 
receptor and this led to the modification seen in 23.24• Compound 23 revealed 
selective antagonist activity for the NK.-2 receptor.2..., Further modifications 
should result in a more useful analogue. 
0 
Compound 24 was designed to be a thyrotropin-releasing-hormone (TRH) 
IS 
analogue.25 TRH is the hypothalamic tripeptide that controls the release of thyroid 
stimulatory hormone from the anterior pituitary gland. TRH also displays effects 
in the brain, blood, spinal cord and the gut. The potency and binding of 24 was 
dependent on the ring fusion stereochemistry in that the isomer with R 
stereochemistry was found to be much more potent than the S isomer. However, 
at high concentrations both stereoisomers displaced 100% of the TRH bound to 
the receptor, but stereoisomer 14 is 4.7 times more potent and had 3.4 times 
greater affinity for the TRH receptor. 
Structure 25 was designed as a non-peptide mimic of an 
immwtosuppressing peptide, tuftsin. 26 This peptide is a naturally-occurring 
tetrapeptide that displays immunostimulatory activity. It was found that 25 blocks 
the stimulatory effect of tuftsin in a sheep red-blood-cell assay in a dose-
dependant fashion. 
Nagai and co-workerr' synthesized 26 in which a sulfur atom is 
incorporated into the 1-azabicyclo[X Y. O]alkane skeleton. This compound is a 
gramicidin S (GS) analogue. GS is a cyclic decapeptide antibiotic that contains 
two P-tums in its structure. When 26 was incorporated in the tum regions of GS, 
the antibiotic activity of this analogue was found to be the same as that of natural 
GS. 
L-Prolyl-L-leucyl-glycinamide (PLG) is an endogenously derived peptide 
that has been shown to control dopamine neurotransmission within the central 
nervous system. Compound 17 was found to exhibit a pharmacological profile 
16 
similar to PLG in terms of activity in binding to dopamine receptors. 21 A type II 
P-tum bas been postulated to be the bioactive conformation ofPLG~ and this spiro 
bicyclic lactam, 27, is believed to mimic this region effectively. 
24 25 
NH1 
H 
0 N,e;ti~H 
0 
26 27 
Compounds 28a, 28b, 28~, 29a, 29b, and 29~ were investigated as thrombin 
inbibitors.29 Thrombin is a trypsin-like serine protease. It is the key terminal 
protease in the coagulation cascade, and it plays a central role in hemostasis and 
thrombosis. 1brombin catalyzes the proteolytic cleavage of the soluble plasma 
17 
protein fibrinogen to form insoluble fibrin leading to clot formation. The 5~6-
fused bicyclic core is postulated to fill the pocket of the active site of thrombin. 
Chromogenic assays were performed with important serine proteases including 
thrombin, trypsin and plasmin. All six compounds were found to be inactive 
against pJasmin Compounds 28e and 29e showed some selectivity for tryps~ 
whereas 28a and 29a were thrombin-selective. However~ lib and 29b exhibited a 
greater potency than 28a and l9a in terms of thrombin inhibition. 
This wide representation of examples illustrates that there is a wide variety 
of potential targets for (}-tum peptidomimetics which contain an 
azabicyclo[X. Y .O]alkane skeleton. 
Another synthetic goal involving these 5,6-fused bicyclic systems could 
include synthesizing analogues of compound 30. (-)-A58365A 30 is a natural 
product that was isolated from the fermentation broth of a soil bacterium. 30 This 
compound is a powerful inhibitor of angiotensin-converting enzyme, an~ as a 
result, this could make the synthesis of analogues of this compound relevant for 
the design of blood-pressure-lowering drugs. Thus, this is a promising area for 
the investigation of other compounds with a similar 5,6-bicyclic backbone. 
18 
lla.a=I;Rt=H 
l8b. a = 1; Rt • BeazyiSOi 
l8c. a =l; R1 =H 
H~ 
OR 
30 
19 
1911. a • I; Rt = H 
29b. D =I; R1 = BeazyiS(h-
29c. D = l: Rl = H 
Results and Discussion 
Initial Attempts 
Several routes were initially proposed to produce a ~}-tum peptidomimetic, 
many of which proved to be unsuccessful. First, it was thought that the 5,6-fused 
bicyclic system could be synthesized using the synthetic route shown in Scheme 9. 
Scbeme9 
31 
m-CPBA, 
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(87%) 
~C~Me 
OH 
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NaOMeiMeOB 
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ScheiBe 9 (continued) 
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38 
ln our initial plan the group at the ring junction of the peptidomimetic 38 
would be a methyl. It was thought that generation of the lactam would be from an 
u-bromoester 37. Treatment of 37 with l equivalent of a base such as NaH would 
result in the removal of the hydrogen atom on the nitrogen of 37 and this anion 
could displace the bromine to generate the desired bicyclic structure 38. The 
synthetic sequence began with 2-methylcyclopentanone 31. A Baeyer-Villiger 
reaction was performed using m-CPBA to produce the lactone 31 in good yield. 
No product with the oxygen inserted on the less hindered side of the ketone was 
detected.31 Subsequent solvolysis of3l under basic conditions yielded compound 
33. Next, the secondary alcohol was protected using TBS-Cl. This was followed 
by bromination of the carbon « to the ester using KHMDS to generate the 
intermediate enolate, to give compound 35. The bromination step did not proceed 
21 
to completion. Since four diastereomers are possible for 35, it was impossible by 
1H NMR spectroscopy to determine the extent of the reaction completion and thus 
the approximate yield. An attempt at separating the starting material 34 from 35 
by flash chromatography proved to be unsuccessful. There was also some concern 
about decomposition of compound 35. As a result, it was decided to isolate the 
desired product in the next step. Removal of the silyl group from 35 using TBAF 
resulted in an alkoxide which unfortunately appeared to displace the bromine to 
generate a cyclic ether. The mass spectrum of the reaction mixture after this 
attempt showed that a bromine atom was not present in the structure. Also, the 1H 
NMR.spectrum revealed signals at 6 3.75 (IH) and 3.40 (3H) which is indicative 
of the ether-type product that would arise from such a process involving 
compound 35. 
The next approach involved a small variation of the previous attempt. 
Compound 38 was now postulated to be produced by ~ synthetic sequence 
shown in Scheme 10. 
22 
Scheme 10 
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The starting compound 39 was obtained by oxidation of the alcohol33 
using PCC. Geminal acylation using the BC13 modification with 9 was conducted 
to afford 40. The yield for this step was low at 34%. However, this can be 
accounted for by partial hydrolysis of the ester functionality during treatment with 
TF A. Next, the Beckmann reaction to produce lactam 41 was attempted without 
success. This reaction produced an intractable mixture of many compounds. As a 
result, focus was shifted to an alternative route (shown in Scheme 11) that was 
being pursued at the same time. If the formation of the 1actam 47 were successful, 
23 
then either a radical or an electrophilic cyclization could be perfonned to generate 
the desired 5,6-bicyclic system. The group denoted CH~ in 48 could be some 
functionality that could easily be-converted into a carboxylic acid. 
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A Grignard reaction was performed with benzaldehyde 42 and the 
organomagnesium reagent derived from 4-bromobutene 43 to produce the alcohol 
44. Subsequent oxidation using PCC furnished ketone 45. Ne~ the geminal 
acylation reaction with 9 provided compound 46. The Beckmann reaction was 
attempted on this substra~ but the resul~ once again, was not the desired lactam 
47. Several products were produc~ but the major product was isolated and 
identified as the diketone 51. A mechanism for its formation is proposed in 
Scheme 12. The formic acid might protonate the double bond before the oxime 
has had a chance to form. This would generate a secondary carbocation 49, which 
would then be attacked by the aromatic ring to produce the benzenonium ion SO, 
followed by regeneration of the aromatic ring to yield compound 51 as a mixture 
of epimers. All spectral information indicate that the assignment of 51 is correct 
but the 13C NMR spectrum is complicated by the presence of both epimers. 
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Investigatioa of the Beekmaaa Reaction 
Each time the Beckmann reaction was attempted using conventional 
conditions, such as using hydroxylamine 0-sulfonic acid in refluxing formic 
acid,32 the result was the destruction of the starting material. It became obvious 
that an investigation of conditions required for the Beckmann reaction was 
necessary. Also, it seemed preferable to initially use a diketo~e without an 
aromatic ring or a double bond. Subsequently, molecules with double bonds or 
aromatic systems could then be examined. The first Beckmann investigation 
involved spiro[4.5]decane-l,4-dione 52 at a concentration of less than 0.4 mmol 
of diketone per mL of formic acid. The result was the desired lactam 53, and 
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recovered starting material 52. 
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When the concentration was adjusted to 0.4 mmol of diketone per mL of 
formic acid, the result was the fonnation of the desired amide 53 and e-
caprolactam 54 (Scheme 13) without any 52 being recovered. Further 
investigation revealed that when 3 equivalents of the aminating reagent were used 
at the same concentration, the result was the fonnation of mainly e-caprolactam as 
seen in Scheme 14. 
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When 4,4-dimethylspiro[4.5]decane-1,3-dione 55 was subjected to the 
same conditions as shown in Scheme ·13, the result was the formation of only the 
desired amide 56 (Scheme 1 5) without any starting material remaining. In 
addition, when the number of equivalents of the aminating reagent was increased 
to 5 equivalents, compound 56 was still the only observed product. 
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The efficient formation of e<aprolactam from 52 with three equivalents of 
the aminating reagent is due to the formation of oximes from both sterically 
unhindered carbonyls, as shown in Scheme 16. 
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The first equivalent of the aminating reagent forms the oxime on one 
carbonyl of compound 52, followed by migration of the quaternary carbon, which 
is succeeded by attack of a molecule of water. After the formation of the lactam 
53, a second oxime is formed on the second ketone moiety. Migration of the 
quaternary center produces the diamide 57. Compound 57 resembles an acetal 
and hydrolysis of this diamide is analogous to hydrolysis of an acetal. This results 
in the production of cyclohexanone 58, which would react with the third 
equivalent of the aminating reagent furnish an intermediate oxime, followed by 
migration to produce e-caprolactam 54. Thus, even though 1.5 equivalents of th~ 
aminating reagent was used under the '~ormal" Beckmann conditions, the 
bimolecular process involving the formation of the second oxime must have been 
in competition with the unimolecular process of migration to produce the 
monoamide product. Both processes must have similar rates. 
An attempt to perform the Beckmann rearrangement with compound 59 
(Scheme 17) did not yield 60, or any significant amount of product with the 
double bond intact. After flash chromatography only one fraction included the 
signal for an amide proton in its 1H NMR spectrum. Unfonunately, this fraction, 
which appeared to be homogeneous by TLC, contained two components. GCIMS 
revealed that the two components probably bad molecular masses of 100 and 115. 
The component with a molecular mass of 100 was suspected to be 
y-valerolactone while the second component could have been 2-phenylaziridine. 
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The 1H NMR spectrum of this mixture contained signals with the same chemical 
shifts as those seen with a commercially available sample of y-valerolactone. 
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Finally 7 the diketone 61 was subjected to the conditions of the Beckmann 
reaction (Scheme 18), but it was found that the amide 61 was not produced in any 
significant amount. Instead, several compounds were formed, one of which may 
have been a derivative of naphthalene. This conclusion is supported by both the 
1H NMR and 13C NMR spectra. The 1H NMR spectrum contained the majority of 
its signals in the aromatic region, with the exception of two signals. One signal 
could be attributed to the methyl groups and the other was consistent with 
methylene hydrogens u to the r;arbonyl. As well, the 13C NMR spectrum 
contained ten signals for aromatic carbons. The ratio of recovered 61 to this 
napthalene by-product was 1:1.8. 
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Thus, after this investigation of the Beckman reaction using conventional 
conditions, the conclusion was reached that these conditions were not compatable 
with our diketones. Diketones derived from 
1 ,2-bis·(trimethylsilyl)oxycyclobutene I would undergo a double Beckmann and 
hydrolysis process. As well, substrates with a double bond in the position shown 
in Scheme 17 were destroyed as were compounds with an aromatic ring. 
Another investigation, (unrelated to the previous work) involving the 
Beckmann reaction was carried out (Scheme 19). It involved trying to determine 
the position of nitrogen insertion for ketones conformationally locked into axial 
and equatorial positions. The Beckmann reaction with compound 63 showed little 
chemoselectivity. Two products 64a and 64b were formed in a ratio of 1 :2. 
Oxime formation and therefore ultimately the position of the nitrogen was not 
influenced much by the carbonyl being either axial or equatorial. However, in 65 
the equatorial carbonyl is flanked by quaternary centers. Sterle hindrance would 
not allow oxime formation on the equatorial carbonyl, therefore only an axial 
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nitrogen was found in the product. Both NOE and X-ray data support these 
results for the position of nitrogen insertion with these substrates. 
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Once it was realized that conventional Beckmann conditions were 
unsuitable with our substrates it was decided to pursue a more gentle aminating 
reagent. 0-Mesitylenesulfonylhydroxylamine (MSH) was then investigated 
because of the example shown in Scheme 20.33 
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With MSH and 67, oxime formation and the subsequent migration occurred under 
very mild conditions, 0 oc in CH2Cl2, to produce the lactam 68. This substrate is 
obviously higher in energy than our diketones since it has a four-membered ring, 
but this result was very encouraging. A drawback to the use of this aminating 
reagent is that it is not commercially available. It must be prepared from ethyl 
acetohydroxamate 69 and mesyl chloride 70, as shown in Scheme 2l.:u MSH can 
be stored below 0 °C, but only for a short period of time in order to remain 
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effective, otherwise it decomposes. 
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The next step involved after the preparation of this aminating reagent 72 
(MSH) was to test it using the diketone substrate 76 (Scheme 22). 
The synthesis of 76 began with the Grignard reaction between 
isovaleraldehyde 73 and the organomagnesium reagent derived from 4-
bromobutene 74 to furnish an alcohol, which was oxidized by PCC to yield the 
ketone 75. The geminal acylation reaction produced the diketone 76, and the 
Beckmann reaction was performed with MSH to give 77. The formation of 
compound 77 was clearly evident by the amide proton present in the tH NMR 
spectrum of the product. 
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Initially, there was a problem with the Beckmann reaction using MSH and 
substrate 76. The oxime formation was observed by 1H NMR spectroscopy but 
the subsequent migration did not occur. Thus, conditions had to be found that 
would promote the migration. Flushing a benzene solution of an oxime through 
basic alumina has been reported to effect migration. Js The result of this process 
with the oxime derived from 76 however only afforded recovery of the unchanged 
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oxime. Another reagent that bas been found to promote migratio~ is BF3·E~O. 
An example36 of the use of this Lewis acid is shown in Scheme 23. 
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Thus, BF3·E~O was also used to promote the migration of the oxime derived from 
compound 76 (Scheme 22). Two interesting aspects of compound 77 is 
complexity observed for the amide proton in the 1H NMR spectrum and the 
complexity of the 13C NMR spectrum. Initially, it was thought that 77 existed in 
the amide form as well as its enol form. It was concluded that these spectra would 
have to be acquired at a higher temperature to observe a simpler spectrum (any 
enol form would convert back to the amide form). However, when higher 
temperatures were attempted during the acquisition of both the 1H NMR and 13C 
NMR spectra. no difference was observed. It was then noticed that the integration 
values for the olefinic protons do not correspond well to the integration for the 
rest of the peaks in the 1H NMR spectrum. This implied that the double bond in 
77 might have been protonated in an earlier step involving TF A and the resultant 
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carbocation would be stabilized by a counterion. This could explain the 
complexity of the spectra for compound 77. The hypothesis of protonation was 
determined after the subsequent cyclization attempts because the variable 
temperature NMR could not be performed as quickly as required. 
Subsequent Attempts at Cyclizatioa 
The next step in this synthetic sequence is crucial since it will form the 
5,6-fused bicyclic system. Initially as proposed in Scheme 119 it was intended to 
proceed with the cyclization either by a radical or an electrophilic method. It was 
decided to first pursue the radical method exemplified37 in Scheme 24. 
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The amidyl radicals such as 82 are produced from N-hydroxypyridine-2-thione 
imidate esters such as 81 and allow for 5-exo-cyclizations to produce y-lactams. 
These esters are related structurally and in their reactions to Barton~s pyridine-2-
thioneoxycarbonyl esters~ which are important carbon-centered radicals. A radical 
trapping agent can be added if required. Otherwise, the carbon-centered radical 
that arises after the cyclization has occurred can also be trapped by the radical 
produced by the 2-thiopyridyl moiety of the intermediate. Thus9 this process was 
attempted with the Iactam 77~ as shown in Scheme 25. 
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The lactam 77 was converted to the imidoyl chloride 83 using phosgene. 
The formation of the imidoyl chloride was foUowed by 1H NMR spectroscopy and 
the conversion occurred smoothly as shown by the complete disappearance of the 
amide proton in the 'H NMR spectrum. Then the sodium salt of2-
mercaptopyridine N-oxide 80 was added to the reaction mixture to produce the 
imidate ester 84. The formation of the imidate ester was also monitored by 'H 
NMR spectroscopy~ and although this step was sluggis~ it did appear to occur. 
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However, the photochemical step proved to be a failure. Irradiation with visible 
light should have generat~ t.!te amidyl radical, which would then have attacked 
the double bond to form the five-membered product 85. Signals for compound 77 
and the mercaptopyridine could be observed in the 1H NMR spectrum of the crude 
material, but upon subjecting the mixture to column chromatography it became 
apparent that these moities were not connected to each other. None of the desired 
cyclized product could be found. 
Attention was then turned to the electrophilic cyclization process shown in 
Scheme 26. Treating the amide 77 with trimethylsilyl trifluoromethanesulfonate 
yielded a silyl imidate,31 which was then treated with iodine to furnish the 
iodonium intermediate 86. Subsequently, cyclization occurred to generate the 
trans and cis iodolactams, 87 and 88 in a4.8:1.0 ratio, respectively. The relative 
stereochemistry of87 was determined by X-ray diffiaction to be a trans 
arrangement. Both the cis and trans product are useful since there are many 
examples throughout the literature in which both types have been shown to be p .. 
turn peptidomimetics. 
The last few steps that are required in order to generate a 13-tum 
peptidomimetic involve conversion of the iodine to an oxygen functionality and 
introduction of the amino group a to the amide carbonyl. 
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Cesium propionate had been chosen for the conversion of the iodine to an 
oxygen function because it is fairly soluble in DMF,39 and also a gentle reagent 
was required since the stability of the iodolactam was not known. Cesium 
propionate attacked the major isomer 87 in a simple SN2 reaction to generate the 
ester 89 and the alcohol 90 (Scheme 21). 
44 
Scheme27 
87 
I 0 &8~ 
DMF 
0 
90 
0 
0~ 0 OH 
+ 
OH 
The formation of the corresponding alcohol 90 in this step was not a concern since 
the ester 89 was to be hydrolyzed to the alcohol 90 in the subsequent step. 
However, alcohol formation was more likely due to the presence of cesium 
hydroxide which would have facilitated the partial hydrolysis of the ester once it 
had formed. 
The next step would have been the introduction of the amino moiety. This 
step was not pursued with 90 because the position of introduction (denoted by *) 
is at a neopentyl carbon. Our planned approach for the introduction of the amino 
group in a less hindered substrate9 was as follows; first, the primary alcohol would 
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have to be protected, then treatment with a strong base, such as KHMDS, should 
generate the anion cz to the carbonyl of the amide. Introduction of trisyl azide 
should then result in the addition of an azide function. Trisyl azide bas been used 
for the introduction of azide cz to an amide,40a as shown for compound 91. This 
reagent is generated from trisyl chloride and sodium azide. 40tJ The example shown 
in Scheme 28 indicates that the azide moiety can be introduced stereoselectively, 
to furnish 92. 
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Hydrogenolysis would then be used to reduce the azide to the amine while leaving 
the amide carbonyl intact. For example, the azide in compound 93 has been 
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selectively reduced to yield 94 while leaving the carbonyls of the amide and ester 
untouched (Scheme 29).41 
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With a successful cyclization method in place, it was decided to synthesize 
the analogous substrate derived from 1,2-bis[(trimethylsilyl)oxy)cyclobutene 1. 
This should provide a substrate in which the amino moiety could be more easily 
introduced. Now the problem encountered was the geminal acylation reaction. 
Very low yields of diketone 95 were obtained from 75 or from its corresponding 
acetal (Scheme 30). Various modifications of the conditions were tried, such as 
changing the Lewis acid, the time of the reactio~ and the temperature, but to no 
avail. 
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Curran and co-workers42 had seen poor yields when the diketone products 
had unsaturation at the 6-position. They reported a set of conditions to effect a 
one-step condensation of 1 and (,)-alkynyl acetals in the presence of excess 
BF3•Et20 at room temperature to provide polycyclic enediones after formation of 
the 1,3-diketone 97. The BF3•Et20-promoted cyclization of the alkynyl ketone 
occurs either via a 5-exo-dig process to produce compound 96 or a 6-endo-dig 
process to produce 98 if the alkyne is terminal (Scheme 31). 
Scbeme31 
96 R 
0 
48 
R=IJ. 
6-endii-dig -~ OBF3 
e 
98 
However, they found that if there is a double bond at the ~ position of the 
dione substrate, the subsequent n:-cyclization occurs but the cyclized product 
cannot be isolated due to decomposition. In a subsequent paper, Curran and co-
workers43 disclosed that the addition of a nucleophile such as Bu,.NBr with these 
substrates was necessary in order to stabilize the carbocation intermediate, 
otherwise the result was the complete decomposition of the substrate. 
This explained our problem with the geminal acylation shown in Scheme 
30 since the !H NMR spectrum of the crude product indicated a lot of 
polymerization. Nonetheless, careful control of the temperature and the time of 
the reaction could reduce the Lewis acid catalyzed 1t-cyclizatio~ as shown by 
Curran and co-workers42 when they successfully performed the geminal acylation 
reaction using the acetal of allyl acetone 99 (Scheme 32). Their addition of the 
reagents was carried out at -78 °C, the reaction was stirred for 3 hours, and then it 
was slowly warmed to 5 oc and quenched after 10 minutes. 
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When this procedure was applied to our acetal 101, the result was the formation of 
the desired diketone 95, but in only 25% yield, along with a significant amount of 
reductive succinoylation product 102 (Scheme 33). 
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Attempt to Prevent Reductive Succinyolation 
Reductive succinoylation originally reported by Kuwajima and co-
workers 1 is the Lewis acid-catalyzed ring-opening of the diketone product to 
produce a y-keto ester. The geminal acylation reaction has been proven to be very 
sensitive to congestion about the acetal carbon. A series of acetals derived from 
ketones with «-methyl groups and l ,2-ethanediol were previously examined by 
Burnell and co-workers,:zc: and the yields ofthe bisacylation products ranged from 
modest to nonexistent because of this reductive succinoylation process. A 
mechanism for the formation of the keto-ester 102 is proposed in Scheme 34. 
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The Lewis acid complexes with one of the carbonyls of the diketone and 
this is followed by nucleophilic attack at that carbonyl. Regeneration of a 
carbonyl can take place with the rupture of the ring and generation of an enol9 as 
shown by structure 103 in Scheme 34. Upon aqueous workup, compound 101 is 
produced. Several attempts were made to stop this acid catalyzed ring opening. 
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The first involved the use of the dimethyl acetall04 instead of one derived from 
1 ,2-etbanediol. The idea was to carry out the reaction in the presence of SA 
Molecular Sieves, using the time and temperature conditions reported by Curran 
and co-workers,42 but then methanol might be trapped before it could initiate the 
reductive succinoylation process (Scheme 35). The use of the Molecular Sieves 
did not improve the disappointing result 
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Another attempt used 10 equivalents of chlorotrimethylsilane, which 
might leave the oxygen moieties of the ethylene glycol less nucleophilic and thus 
stop the ring-opening process. The result was also not promising (Scheme 36). 
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The yield was not determined in this reaction since the formation of the reductive 
succinoylation product was clearly evident in the crude 1H NMR spectrum. The 
ratio of compound 95 to compound 102 was 1:4.3. 
In the past, there had been some success in curbing reductive 
succinoylation in our laboratory using an acetal derived from a more hindered 
diol92c as shown in Sc!teme 37. The increased bulk of the diol made it less capable 
of approaching the diketone to cause the ring opening process. 
53 
Scheme37 
BFtEtzO.l • 
CH1CI2, -78°C 
BF~Et20,l 
• CB1Cl2, -78°C 
(56./e) 
crude 
0~08 
0 
It was decided to try the geminal acylation with the acetal 106~ which was 
made from technical grade (::1::)-2~3-dimethylbutanediol (Scheme 38). The geminal 
acylation reaction proved to be very sluggish. Much of the parent ketone 75 was 
recovered along with the desired diketone substrate 95. It was proposed that the 
diketone product might be produced in better yield if the number of equivalents 
of 1~-bis[(trimethylsilyl)oxy]cyclobutene 1 were increased. This was certainly 
the case, as can be seen in Scheme 38. An interesting aspect of this reaction is 
that the acetal recovered was entirely the(::!::) form of the acetall06a. which led to 
the conclusion that the meso-form ofthe acetal reacted more readily. 
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At the same time as pursuing the problem of reductive succinoylation it 
was decided to proceed with the synthesis of a simpler P·turn peptidomimetic. 
Since Curran and ca.workers42 had shown that the geminal acylation of allyl 
acetone could proceed in 67% yiel~ this substrate was utilized in this synthesis. 
The geminal acylation reaction of the acetal99 gave the desired diketone 100 in a 
better yield than that reported by Curran and ca.workers42 (Scheme 39). 
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The next step was the Beckmann reaction of compound 100 using MSH. 
It was not known if the conditions required for the migration of the quaternary 
center (BF3·E~O~ reflux) would also result in undesired Lewis acid catalyzed 1t-
cyclization. Curran and co-workers43 reported that the 1r-cyclization could occur 
with 100. However .. this was not the case since the yield of 107 was fairly good at 
60%. The next step proved to be fatal in this route since 4-iodobutanol108~ 
formed from THF, was isolated instead of the desired cyclized product. In 
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additio~ the intermediate 109 was thought to be present in the crude mixture as 
determined by the 1 H NMR. spectrum. There is a precedeotllb for the formation of 
4-iodobutanol during the synthesis of other iodolactams. The only reasonable 
source of108 was from the solvent THF, which suggests that THF becomes 
silylated during the course of the reaction and is ultimately cleaved upon workup. 
When this same cyclization was performed with endo-5-norborene-2-carboxamide 
110 (Scheme 40) using tert-butyldimethylsilyl trifluoromethane sulfonate as the 
silylating agen~ the result was the formation of the N.O-bis(silyl) derivative 111. 
This was treated with 12 in THF. and work-up consisted of adding sodium sulfite 
only and omitting the sodium bicarbonate, although both are used in the "usual" 
work-up for this cyclization step. The result was the formation of the N-(lert-
butyldimethylsilyl)lactam, 113 and the silylether of 4-iodobutanol 115 as shown 
in Scheme 40. Further treatment with water produced 4-iodobutanol 108. Thus, 
the cyclization occurred to provide initially the iminium species Ill, the 0-silil 
group of which was transferred to the oxygen ofTHF to give the siloxonium 
species 114. Compound 114 was then opened by either iodide ortriiodide leading 
to the silyl-protected form of 4-iodobutanol115. Treatment of 113 with aqueous 
NaHC03 resulted in the formation of the desired compound 116. 
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It is likely that in our case the formation of species 117 was involved in 
this ring cleavage ofTHF since 2.2 equivalents of both Et3N and TMS-OTf were 
used (Scheme 41 ). This was not possible with compound 88 in Scheme 26 since 
the u-carbon of the ketone was quaternary. Consequently, when THF is added to 
the reaction mixture, one of the silyl groups from groups 117 can transfer to the 
oxygen ofTHF allowing for iodide or triiodide to cleave THF. This leaves little 
or no iodine to add across the double bond of compound 109. As a result, the 
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cyclization could not occur and the intermediate 109 was still present in the 
reaction mixture as seen by the 1H NMR spectrum. 
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In order to avoid this it was necessary to either reduce selectively one of 
the ketones before cyclization so that double enol formation cannot occur~ or use a 
different solvent. A number of solvents have previously been examined for this 
cyclization such as pentane~ dichlonnethane, toluene, acetonitrile, carbon 
tetrachloride, ether and dioxane but all proved to be less than satisfactory.31b The 
efficacy ofTHF is due in part to its ability to dissolve 12 and its Lewis basicity. As 
a consequence, the selective reduction of one of the ketone moities was pursued. 
This was ultimately going to be done anyway since the original proposal was for a 
chiral, non-racemic route to a potential P-tum peptidomimetic. 
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Chiral, Non-racemic Route 
The monoreduction of the diketones was planned to occur by the use of baker's 
yeast. 9b This was investigated as outlined in Scheme 42. In additio~ microbial 
monoreduction was also attempted with the cyclic amide 107, but only starting 
material was recovered. 
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The diketone 100 underwent microbial reduction to produce the alcohol118 in a 
1 :9 diastereomeric ratio. Difficulty was encountered in trying to separate these 
alcohols by flash chromatography at this poin~ so the mixture was protected using 
TBS-Cl. The Beckmann reaction was performed with 119 using MSH to produce 
the desired lactam 120. The cyclization to furnish the iodolactam 121 was carried 
o~ but the yield was only 30%. A fraction containing only the major isomer 121 
was isolated after column chromatography with a yield of 14%. A mixture of the 
two isomers was also observed with a yield 16% and a ratio of 4.2:1.0 for 121 and 
its isomer. The relative and absolute stereochemistry of 121, the major isomer, 
was determined using X-ray diffraction. 
The next step in the synthetic sequence was the SN2 reaction using cesium 
propionate to produce the ester 123. A significant amount of the E2 elimination 
product 122 was also observed. This was attributed to decomposition of the 
cesium propionate to cesium hydroxide. A strong base is required in order to 
facilitate this elimination. As a resul~ when this reaction is carried out again in 
the future freshly prepared cesium propionate should be used The last step 
required for the synthesis of a potential P-tum peptidomimetic would be the 
introduction of the amine moiety cz to the amide carbonyl., but this step was not 
conducted due to a lack of material. It was felt that a more pressing matter was an 
effort to diastereoselectively reduce a diketone such as 100 using chemical 
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methods. The reduction of 100 with (S)-CBS-oxazaborolidinone 124 (Scheme 
43) could be accomplished on a larger scale than was practical with yeast. 
Initially, there were concerns that the reduction would occur on either or both of 
the carbonyl carbons, as well as reduction of the double bond. The reduction was 
executed using both BMS and then BH3•THF but reduction of more than one of 
the carbonyls was obsenred in the 1 H NMR. spectrum. Next, the reduction was 
also perfonned using catecholborane, 125 a less reactive monohydride reagent. 
This reagent permits CBS reductions to occur (with excellent enantioselectivity)44 
at temperatures as low as -126 °C in noncoordinating solvents such as 
dichloromethane or toluene. Also, the decreased reactivity of catecholborane 
compared to BH3, especially at lower temperatures, minimizes both the 
uncatalyzed ketone reduction and hydroboration of sensitive functional groups 
such as double and triple bonds as well as other carbonyl moieties within the 
ketonic structure.44 The proposed mechanism for the CBS reduction of 100 is 
shown in Scheme 43. Based on this mechanism it is relatively easy to predict the 
major diastereomer, (2S,3S)-2-(3-Butenyl)-3-hydroxy-2-methyl- cyclopentanone 
118, for the chemical reduction using (S)-CBS-oxazaborolidine. The 
diastereomeric ratio for the chemical reduction of compound 100 was 1:9. The 
major diastereomer from the chemical reduction and the microbial reduction were 
the same, as shown from the 1H NMR spectra for both. Thus, the prediction of the 
major diastereomer from Scheme 42 is consistent with the determination of the 
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absolute stereochemistry from X-ray diffiaction analysis for compound 121. 
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Ring opening of2,l-dimethyl-bls-[(trimethylsilyl)oxyJeyclobutene (9) 
An interesting and unexpected result that was found during the course of 
this work occurred during the first attempt at the acyloin condensation reaction to 
produce 3,3-dimethyl-1~-bis[(trimethylsilyl)oxy)cyclobutene 9. During the 
course of synthesizing compound 9, solvent is removed by simple distillation. 
The first attempt at the acyloin condensation reaction resulted in the application of 
too much hea~ and 9 began to distill. Subsequen~ high vacuum distillation gave a 
mixture of the desired product 9 as well as the ring-opened product 126 (Scheme 
44). The structure of 126 was deduced from the following spectroscopic data: the 
1H NMR spectrum showed two signals indicative of olefinic protons at~ 4.40 and 
429 as well as two distinct methyl signals at ~ I. 77 and 1.65. Compound 9 
contains two methyl groups as well, but they are chemically equivalent. 
Scheme44 
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These two isomers could not be separated by high vacuum distillation. In order to 
trap diene 126, a Diets-Alder reaction using N-phenylmaleimide 127 was 
conducted (Scheme 45) 
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After flash chromatography using a very short column, a fraction was 
isolated for which the 1H NMR spectrum was consistent with the structure of 
adduct 128. Signals for aromatic protons were clearly evident as well as two 
signals indicative of the protons at the ring junctions at ~ 3.34 and 3 .22. Also, 
signals at l) 2. 92 and 2.53 were speculated to be the allylic protons. The low 
resolution mass spectroscopy clearly showed a mass indicative of the product 128 
with a loss of a methyl group. Unfortunately, when the 13C NMR spectrum was 
acquired, some evidence of hydrolysis was observed. Two signals were present 
which were characteristic of the amide carbonyls but there was also a ketonic 
carbonyl signal. Thus, the results were not conclusive, but there was some 
evidence to indicate that the diene 126 had been napped to produce the desired 
Diels-Alder adduct. 
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Considerations for Future Work 
Several other sizes of fused-bicyclic ring systems could also be used as 
potential13·tum peptidomimetics. Throughout the literature there are many 
instances of similar ring systems being used to mimic different types of 13·tum 
peptidomimetics as shown in Figure 4.12 As stated before, the group located at the 
ring junction of these potential peptidomimetics in the literature12 is exclusively 
hydrogen. Future work would consist of generating several of these differently-
sized bicyclic ring systems. The synthesis of such compounds might be 
accomplished using the Iactams shown in Scheme 46. These Iactams could be 
synthesized using the reductio~ protection and Beckmann reactions shown in 
Scheme 42. Compound 129 could be used to generate the 6,6-bicyclic system, 
while 130 and 131 could be used to produce the 5,7- and the 6,.7-fused bicyclic 
systems. 
F"agure 4: Examples of Other Fused-Ring Systems 
H 
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These bicyclic systems have not been as widely investigated as the 5~6-system but 
this would definitely be an area to focus on in future. 
Finally, the chemical reduction would have to be pursued further to make 
this synthetic sequence viable so that the introduction of the amino moiety can be 
accomplished. 
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Experimental Section 
General Procedures: 
Compounds 1 and 9 were prepared by the method of Bloomfield and 
Nelke.45 Flash chromatography ("chromatographyn) used 240-400 mesh silica 
gel. IR spectra were recorded on the Mattson FT -IR instrument as thin films~ 
unless otherwise stated. Relative intensities of the absorption bands are recorded 
using the foUowing abbreviations: s (strong), m (medium), w (weak), and b 
(broad). 1H NMR spectra were obtained on either a General Electric GE-300 NB 
spectrometer at 300 MHz in CDC13 or a Bruker A vance spectrometer with a TXI 
inverse-detect gradient probe at 500 MHz in CDC13• Unless otherwise stated~ 
shifts are relative to internal tetramethylsilane and coupling constants are in Hz. 
The following abbreviations are used in the description of multiplicities in the 1H 
NMR spectra: s (singlet), d (doublet), t (triplet)~ q (quartet), m (multiplet) n 
(narrow), b (broad), and sep (septet). The nc NMR spectra were recorded at 75 
MHz on the General Electric GE-300 NB spectrometer, and at 125 MHz on the 
Broker A vance 500 MHz instrument. Shifts were measured relative to a solvent 
resonance. The number of attached protons was determined by an attached proton 
test (APT) and heteronuclear correlations for the GE-300 NB spectrometer, and by 
using distortionless enhancement by polarization transfer (DEPT) and 
heteronuclear multiple quantum correlation (HMQC) on the Bruker A vance 500 
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MHz instnunent. NMR. free induction decay data were processed using WinNuts 
(Acorn NMR software). Low resolution mass spectral data were recorded on the 
V.G. Micromass 7070HS instrument. High resolution mass spectra were obtained 
from the University of Ottawa mass spectral facility. Melting points were 
determined using a Fisher·Johns hot stage apparatus and were uncorrected. Mr. 
David Miller obtained data for the X-ray structures of compounds 64a, 66, 87, and 
121 on a Rigaku AFC6S difractometer. The data solution and refinement were 
performed using teXsan software. Dichloromethane, DMF, and pentane were 
distilled from CaH2• THF and toluene were distilled from sodium metal. 
General Pro~edure for Geminal Acylation. 
Compounds 40, 46, and 76 were prepared based on the methods developed in our 
laboratory.4..5·6 Compounds Sl and 63 were prepared based on the method of 
Jenkins and Burnell. 4 Compounds 55, 61, and 65 were provided by Dr. Sheldon 
Crane. Compounds 95 and 100 were generated based on the method of Curran 
and coworkers. 43 
Methyl 4-(1,4,4-trimetbyl-1,3-dioxocyelopent-2-yl)butanoate { 40) 
1 .. 
l" BC13 (12.8 m.L, 12.8 mmol) and then 9 (3.33 g~ 
1 
40 
12.9 mmol) in CH2Cl2 (4 mL) were added to a 
solution of39 (1.15 g, 7.99 mmol) in CH2Cl2 
t OMe 
(16.5 mL) at -78°C and warmed tort overnight. 
The mixture was recooled to • 78°C before a 
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solution of 50% HF (6.4 mL) in MeOH (14 mL) was added and the mixture was 
stirred for 15 minutes. The mixture was warmed tort and stirred for I hour. The 
mixture was concentrated under reduced pressure. TF A (24 mL) was added and 
the mixture was stirred at rt for 24 hours. Aqueous workup consisted of adding 
H20 (100 mL) and CH2Cl2 (SO mL). Solid NaHC03 was added until neutral pH 
was obtained. The organic layer was washed with H20 (100 mL) and the aqueous 
layer was back extracted with CH2Cl2 (3 x 100 mL ). The combined organic layers 
were washed with brine (100 mL) and dried over anhydrous MgS04• The solution 
was concentrated under reduced pressure. Flash chromatography using 50% ethyl 
acetatelhexanes fumis~ed 40 (653 mg, 34%) as a yellow liquid: IR vnwt 2962 (m), 
1752 (bs), 1722 (bs) em·•. 'H NMR (CDC13): o 3.65 (3H, s,. Me), 2.68 (lH, d, J= 
18.3 ~ H-5'), 2.60 (1H,. d, J= 18.3 Hz, H-5'), 2.25 (2H, t, J= 6.8 ~ H-2), 1.52 
(4H, m, H-3, H-4), 1.25 (6H, s, H-1" and H-2"), 1.17 (3H, s, H-1*). 13C NMR 
(CDC13): o 221.1 (0, C-3'), 216.4 (0, C-1'), 173.3 (0, C-1), 56.3 (0, C-2'), 51.8 (3, 
Me), 51.1 (2, C-5'), 46.5 (0, C-4'), 35.1 {2,. C-4}, 34.1 (2, C-2), 26.8 (3, C-1" or C-
2"), 25.1 (3, C-1" or C-2"), 21.0 (1, C-1•), 20.5 (2, C-3). MS mlz(%): 240 (10, 
~). 166 (26), 153 (10), 128 (40), 125 (15), 113 (21), 97 (12), 83 (32), 82 (33), 74 
(16), 69 (83), 68 ( 17), 59 (11 ), 56 (19), 55 (27), 43 (21 ), 41 (1 00), 39 (27), 29 
(18), 27 (19). HRMS calcd for C 13H200 4: 240.1360; found: 240.1348. 
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2-(3-Butenyl)-4,4-dimetbyl-2-pbenyl-1,3-cyclopentanedione ( 46) 
I"' 
l' 46 
A solution of 45 (328 mg, 2.35 mmol), 9 (833 mg, 
3.22 mmol), and BF3•El:20 (0.41 mL, 3.2 mmol) in 
~ CH2CI2 (10 mL) was stirred at rt for 25 hours . 
.!'/ "" 
Aqueous workup consisted of adding H20 (30 m.L) 
followed by CH2Cl2 (30 mL). The organic layer 
was washed with H20 (2 x 30 ml) and the aqueous layer was back extracted with 
CH2Cl2 (3 x 30 mL). The solution was concentrated under vacuum. Flash 
chromatography using 40% ethyl acetatelhexanes provided 46 ( 248 mg, 4 7%) as 
a yellow liquid: IR vi11U 3064 (m), 1751 (s), 1721 (s) em·'. 1H NMR (CDC13): 6 
7.29 (5H, m, H-2', H-3', H-4', H-5', H-6'), 5.68 (lH, m, H-3"), 4.93 (2H, m, H-4"), 
2.71 (IH, d,J= 18.1 ~ H-5), 2.50 (lH, d,J= 18.1 ~ H-5), 1.91 (4H, m, H-2" 
and H-1 "), 1.22 (3H, s, H-1"' or H-2·), 1.16 (3H, s, H-1"' or H-2·). 13C NMR 
(CDC13): 6 218.2 (0, C-3), 213.2 (0, C-1), 137.6 (1, C-3"), 136.4 (0, C-1 '), 129.4 
(1, C-6' and C-2'), 128.0 {1, C-4'), 126.7 (1, C-3' and C-5'), 115.5 (2, C-4"), 65.4 
{0, C-2), 51.5 (2, C-5), 46.8 {0, C-4), 36.6 (2, C-1"), 30.0 (2, C-2"}, 26.9 (3, C-1· 
or C-2·), 25.7 (3, C-t· or C-2·). MS m/z (%): 256 (1, M}, 215 (19), 202 (30}, 
131 (71), 103 (100), 77 (14), 41 (11). HRMS calcd for C 17H200 2 : 256.1462; 
found: 256.1460. 
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Spiro[4.5]decane-l,4.ctione (52) 
52 
To a solution of cyclohexanone (620 mg, 6.32 mmol) and 
O BF3•Etz0 (0.96 mL, 7.6 mmol) in CH2Cl2 (25 mL) at -78°C 
was added l (2.21 g, 9.67 mmol) in CH2Cl2 (14 m.L). The 
mixture was stirred at this temperature for 3 hours before it 
was allowed to attain rt. H20 (0.96 mL) was added. and the 
mixture was cooled again to -78°C before more BF3•Etz0 (14.4 m.L, 113 mmol) 
was added. The mixture was allowed to attain rt overnight. Aqueous workup 
involved washing the mixture with H20 (2 x 100 mL), back-extracting with 
CH2Cl2 (3 x 100 mL), washing the combined organic layers with brine (100 mL) 
and drying over anhydrous MgS04• The solvent was reduced in volume to 50 mL 
and the resulting solution was flushed through a Florisil column containing 
activated charcoal to yield 52 (956 mg, 91%) as a white solid: mp 60-62°C (lit.2b 
61-62°C). 1H NMR (CDC13): 6 2.74 (4H, s), 1.73-1.46 (lOH, m). 13C NMR 
(CDC13): 6 215.6, 55.8, 34.2, 29.1, 24.9, 20.4. 
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8-tert-Butylspiro[4.5]deeane-1,4-dione (63) 
To a solution oftert-butylcyclohexanone (490 mg, 3.17 
O mmol) and BF3·E~O (0.49 mL, 3.9 mmol) in CH1Cl2 (20 mL) 
at -78°C was added 1 (1.11 g, 4.86 mmol) in CH2CI2 (10 mL). 
The mixture was stirred at-this temperature for 3 hours before 
it was allowed to attain n. H20 (0.49 mL) was added, and the 
63 mixture was cooled again to -78°C before more BF3·E~O (6.1 
mL, 48 mmol) was added. The mixture was allowed to attain n overnight. 
Aqueous workup involved washing the mixture with H20 (2 x 100 mL), back-
extracting with CH2CI2 (3 x lOOmL), washing the combined organic layers with 
saturated NaCl (140 mL) and drying over anhydrous MgS04• The solvent was 
reduced to 50 mL and the resulting solution was flushed through a Florisil column 
containing activated charcoal to yield 63 (549 mg, 78%) as a white solid: mp 81-
83°C (lit.'' 82.5-84°C). 1H NMR (CDC13): ~ 2.76 (4H, b s), 1.75-1.46 (9H, m), 
0.88 (9H, s). 13C NMR (CDCI3): 6 216.0, 215.9, 55.8, 46.9, 34.5, 34.3, 32.4, 30.1, 
27.3, 21.6. 
2-(3-Buteayl)-2-isobutyl-4,4-dimetbyl-1,3-cydopeatanedione (76) 
BC13 (28.0 mL, 28.0 mmol) and then 9 (11.0 g, 
42.5 mmol) in CH1Cl1 (18.5 mL) were added to a 
.a• solution of75 (3.84 g, 27.4 mmol) in CH2C12 (50 
I' l' 
76 mL) at -78°C, and warmed to rt overnight. The 
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mixture was recooled to -78°C before a solution of 500/o HF (22.6 mL) in MeOH 
(48.5 mL) was add~ and the mixture was stirred for 15 minutes. The mixture 
was warmed to rt and stirred for 1 hour. The reaction mixture was concentrated 
under reduced pressure. TF A (77 mL} was added and the mixture was stirred at rt 
for 24 hours. Aqueous workup consisted of adding of water (200 mL) and solid 
NaHC03 until neutral pH was obtained. The organic layer was washed with H20 
(100 mL) and the aqueous layer was back extracted with CH2Cl2 (3 x 150 mL). 
The combined organic layers were washed with brine (150 mL) and dried over 
anhydrous MgS04• The solution was concentrated under vacuum. Flash 
chromatography was conducted eluting with 10% ethyl acetatelhexanes to yield 
76 (3.46 g, 54%) as a colorless liquid: IR vmu 2960 (bm), 1761 (s), 1720 (s) em·'. 
1H NMR(CDC13): 6 5.69 (lH, m, H-3'), 4.96 (2H, m, H-4'), 2.69 (lH, d.,J= 18.8 
Hz, H-5), 2.60 (lH, d,J= 18.8 Hz, H-5), 1.89 (2H, m, H-2'), 1.68 (5H, m, H-1', 
H-1" and H-2"), 1.30 (3H, s, H-1· or H-2j, 1.25 (3H, s, H-1· or H-2·), 0.83 (6H, 
apparent t, J= 5.32 Hz, H-3" and H-4"). nc NMR (CDC13): 6 220.7 (0, C-1 or C-
3 ), 215.9 (0, C-1 or C-3), 137.3 (1, C-3'), 115.5 (2, C-4'), 61.0 (0, C-2), 51.2 (2, 
C-5), 45.8 (0, C-4), 43.8 (2, C-1' or C-1 "), 34.8 (2, C-1' or C-1"), 28.7 (2, C-2'), 
26.6 (3, C-1· or C-2j, 26.3 (3, C-1'· orC-2•), 24.9 (1, C-2"), 24.3 (3, C-3" or C-
4"), 24.2 (3, C-3· or C-4·). MS mlz (%): 182 (37, M"- C4~), 140 (42), 139 (10), 
111 (85), 109 (25), 93 (20), 81 (30), 79 (10), 67 (16), 56 (16), 55 (59), 53 (18), 43 
(31), 41 (100), 40 (12), 39 (32), 29 (32), 27 (32). 
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2-(3-Butenyl)-l-isobutyl-1,3-cyclopentanedione (95) 
l" .... 95 
BF3·E~O (0.63 mL, 5.0 mmol) was introduced slowly to 
A 4• a solution of 106 (lOS mg, 0.496 mmol) in CH2Cl2 
(4.95 mL) at -78°C. After 10 minutes, 1 (0.60 g, 2.6 
mmol) was added to the mixture, and the mixture was 
stirred at -78°C for 3 hours. The mixture was slowly warmed to 5°C, and after ten 
minutes the mixture was diluted with E~O (15 mL), H20 (15 mL) and then 
extracted with E~O (3 x 20 mL). The combined organic extracts were washed 
with brine (25 mL) and dried over anhydrous MgS04 • Flash chromatography was 
performed eluting with 20% ethyl acetatelhexanes to yield 95 (31.0 mg, 30%) as a 
yellow liquid. The recovery of the starting material106a was entirely the d/1 
form (25%). IR vmax 2958 (bm), 1764 (s), 1722 (s) em·'. 'H NMR (CDC13): 5 
5.63 (1H, m, H-3'), 4.95 (2H, m .. H-4'), 2.76 (4H .. s, H-4 and H-5), 1.92 (2H, m, 
H-2'), 1.62 (5H, m, H-1', H-1" and H-2"), 0.77 (6H, d,J= 6.7 ~ H-3" and H-4"). 
13C NMR (CDC13): 6 217.4 {0, C-3 and C-1 ), 137.3 (1, C-3'), 115.9 (2, C-4'), 60.4 
(0, C-2), 44.5 {2, C-1' or C-1 "), 36.3 (2, C-1' or C-1"), 36.2 (2, C-4 and C-5), 28.8 
(2, C-2'), 25.2 (3 .. C-3" or C-4"), 24.0 (2C, 1 and 3, C-2" and C-3" or C-4"). MS 
mlz (%): 208 (1, M'), 154 (60, ~-c.~), 152 (12), 125 (14), 112 (100), 111 (37), 
107 (15), 81 (13), 67 (11), 55 ( 31), 53 (11), 43 (22), 41 (47), 39 (17), 29 (19), 28 
(16), 27 (23). 
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(tVI)-2-Metbyl-pentyl-7-oden-4-one, 2,3-butanediol acetal (106a) 
1" 
4' Colorless liquid: 1H NMR. (CDC13): lS 5.84 (lH~ ~ 
5 
106a 
H-7)~ 4.97 (2H, m~ H-8), 3.61 (2H, m, H-1', H-2'), 
A I 2.13 (2H, m.. H-6), 1.78 (1H, ~ H-2), 1.71 (2H, ~ 
7 
H-5), 1.53 (2H, d, J= 6.2 Hz, H-3), 124 (3H, s, H-
3' or H-4')~ 1.22 (3H, s, H-3' or H-4'), 0.95 (6H, apparent t, J= 6.7 Hz, H-1 and 
H-1"). 13C NMR. (CDC13): 6 139.3 (1, C-7)~ 114.5 (2, C-8), 111.2 (0, C-4), 79.0 
(1, C-1' or C-2'), 78.7 (1, C-1' or C-2'), 47.3 (2, C-3), 38.2 (2., C-5), 28.3 (2, C-6), 
24.6 (3, C-3' arC· 4'), 24.3 (3, C-3' orC-4'), 17.3 (3, C-1 orC-1'), 17.0 (3, C-8 or 
C·l '). 
2-(3-Butenyl)-2-metbyl-1,3-cyclopentanedione (100) 
Compound 99 (758 mg, 5.33 mmol) was dissolved in 
CH2Cl2 (53 mL) and the reaction mixture was cooled to-
100 
dropwise and after ten minutes, 1 ( 1.61 g, 7.00 mmol) 
was introduced slowly. The mixture was stirred at -78°C for 3 hours before it was 
warmed to soc . The mixture was stirred at this temperature for ten minutes, then 
the mixture was diluted with E~O (35 mL) followed by H20 (35 mL) and 
extracted with E~O (3 x 50 mL ). The combined organic extracts were washed 
with brine (75 mL) and dried over anhydrous MgS04• The solution was 
concentrated under vacuum. Flash chromatography was performed eluting with 
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33% ethyl acetatelhexanes to produce 100 (677.1 mg, 76%) as a colorless liquid: 
IR v- 2927 (s), 1765 (m), 1722 (s) cm·1• 1H NMR (CDC13): 6 5.64 (lH, m), 4.94 
(2H, m), 2.77 (4H, m), 1.96 (2H, m'), 1.77 (2H, m), 1.12 (3H, s). 13C NMR 
(CDC13): 6 216.8, 137.5, 116.0, 56.4, 35.3, 34.3, 29.3, 20.3. MS mlz (%): 166 (3, 
~). 125 (28), 112 (I 00), 97 (1 5), 69 (37), 41 (55), 39 (19), 28 (17), 27 (20). 
General Procedure for the Beckmann Reaction using NB1SOJIIBC01H 
Compounds 51, 53, 56, 64a, 64b, and 66 were prepared based on the method of 
Olab and Fung.32 
I' ,2' ,3' ,4'-Tetrahydro-1 ',4,4-trimethylspirocyclopentane-2-naphtbalene (51) 
I'" 
51 I"" 
A solution ofNH20S03H ( 180 mg, 1.60 mmol) and 46 
1"' (258 mg, 1.00 mmol) in 98o/o formic acid (2.5 m.L) was 
heated under reflux for 2 days. The mixture was cooled 
to rt, then in an ice bath which was followed by the 
addition of H20 (10 mL). The mixture was adjusted to a 
pH of9-10 using 20% NaOH. Workup consisted of 
extracting with CHC13 (4 x SO mL) and drying the combined organic extracts over 
anhydrous MgS04• The solution was concentrated under vacuum. Flash 
chromatography was performed using 20% ethyl acetatelhexanes to yield 51 as the 
major product ( 1 5.3 mg, 6%) a tan colored resin. The 13C NMR spectrum was 
complicated by the presence ofboth epimers. IR viiUIX 2962 (m), 1765 (m), 1721 
(s) em·•. 1H NMR (CDCl3): 6 7.41-7.17 (3H, m, H-6', H-7' and H-8'), 6.64 (lH, d, 
77 
J= 7.3 Hz, H-9'), 3.11 (2~ ~ H·l' and H-5), 2.79 (HI, m, H-5), 2.24-2.01 (3H, 
m. H-2' and H-3'), 1.82 (IH, m, H-3'), 1.56 (3H, 2 s, H-t· or 2•), 1.55 (3H, 2 s, H-
I .. or 2 .. ) 1.45 (3H, dd, J = 1.3 Hz, 30.2 Hz, H-1 j. 13C NMR. (CDCl3): ~ 220.1, 
219.6, 143.9, 143.8, 129.1, 128.9, 128.7, 128.0, 126.5, 120.5, 51.0, 50.9, 46.7, 
32.2, 32.0, 30.4, 29.9, 26.9, 26.8, 26.5, 26.3, 26.1, 25.9, 23.1, 23.0, 22.8, 22.7. 
MS mlz (%): 256 (0.2, ~ ), 146 (9), 117 ( 11 ), 104 (1 00). HRMS calcd for 
C 17H200 2: 256.1462; found: 256.1443. 
l-Azaspiro[5.5)undeeane-2,5-dione (53) 
0 
53 
A solution ofNH20S03H (106 mg, 1.00 mmol) and 52 (103.6 
mg, 0.6233 mmol) in 98% formic acid (1.56 mL) was heated 
under reflux for 2 hours. The mixture was cooled to 1'4 then in 
an ice bath which was followed by the addition of H20 (10 mL). 
The mixture was adjusted to a pH of9-10 using 20% NaOH. 
Workup consisted of extracting with CHCl3 (5 x 30 mL) and drying the combined 
organic extracts over anhydrous MgS04• The solution was concentrated under 
vacuum. Flash chromatography was performed using 75% acetone/hexanes to 
yield 53 (51.1 mg, 45%) and 54 (6.2 mg), both as white solids. Physical data for 
compound 53: mp 187-18gc'C. IR (Nujol) vmax 3425 (m), 1713 (m), 1657 {m) em· 
1
• 
1H NMR(CDCl3): o 6.94 (lH, bs, H-1), 2.69 (4H, s, H-3 and H-4), 1.52-1.80 
(IOH, m, H-7, H-8, H-9, H-10, H-11). 13C NMR (CDC13): o 208.9 {0, C-5), 171.6 
(0, C-2), 63.3 (0, C-6), 32.0 (2, C-4), 31.6 (2, C-7 and C-11), 26.2 (2, C-3), 21.8 
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(2, C-8 and C-10), 17.7 {2, C-9). MS m/z(%): 181 (0.1, ~}, 153 (62), 110 (18), 
98 (59), 97 (100), 96 (16), 82 (18), 81 (11), 69 (34), 57 (22), 56 (12), 55 (17), 54 
(41), 42 (12), 41 (34), 39 (18), 30 (14), 29 (15), 28 (39), 27 (35). HRMS calcd for 
e-Caprolactam (54) 
0 mp 66-69°C (lit.46 70-72°C). 1H NMR (CDC13): a 7.16 {lH, b s), 3.20 
,). NJI (2H, m), 2.45 (2H, m,), 1.69 ( 6H, m). 13C NMR (CDCI3): 6 197 .6, u 42.8, 36.8, 30.7, 29.8, 23.3. 
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1-Aza-4,4-dimethylspiro [5.5]undecane-2,S-dione (56) 
1. 
t• 
A solution ofNH20S03H (77.9 mg, 0.689 mmol) and 55 (86.3 
0 
mg, 0.444 mmol) in 98% formic acid (1.1 mL) was heated 
under reflux for 3 hours. The mixture was cooled to rt, then in 
an ice bath which was followed by the addition ofH20 (15 
56 mL ). The mixture was adjusted to a pH of 9-1 0 using 20% 
NaOH. Workup consisted of extracting with CHC13 (4 x 30 mL) and drying the 
combined organic extracts over anhydrous MgS04• The solution was 
concentrated under vacuum to yield 56 (73.3 mg, 79%) as a white solid: mp 186-
18CJOC. IR (CC14) vmax 2928 (m), 1721 (m), 1672 (m) em·•. 'H NMR (CDC13): a 
6.45 (lH, b s, H-1), 2.51 (2H, s, H-3), 1.79 (4H, ~ H-7, H-11), 1.37 (5 H, m, H-
8, H-10 and H-9), 1.20 (6H, s, H-1' and H-2'). 13C NMR (CDC13): a 212.4 (0, C-
79 
5), 170.2 (0, C-2), 62.8 (0, C-6), 42.6 (2, C-3), 42.2 (0, C-4), 34.6 (2, C-7 and C-
11), 24.5 (3, C-1' and C-2'), 24.3 (2, C-9), 20.3 (2, C-8 and C-10). MS mlz (%): 
209 (3, ~), 181 (54), 138 (22), 110 (13), 98 (100}, 97 (99), 96 (12}, 82 (13), 81 
(10), 69 (20), 57 (10), 56 (29), 55 (23), 54 (39), 53 (11), 42 (11), 41 (57), 39 (25), 
29 (20), 28 (30), 27 ( 1 7). 
cis-1-Aza-9-tert-butylspiro[S.S]undecane-2,5-dione (64a) 
64a 
0 A solution ofNH10S03H (23.4 mg, 0.207 mmol) and 63 (25.5 
mg, 0.145 mmol) in 98% formic acid (1.6 mL) was heated 
under reflux for 3 hours. The mixture was cooled to rt. then in 
an ice bath which was followed by the addition ofH20 (10 
mL). The mixture was adjusted to a pH of9-10 using 20o/o 
NaOH. Workup consisted of extracting with CHC13 ( 4 x 25 
mL) and drying the combined organic extracts over anhydrous 
MgS04• The solution was concentrated under vacuum. Flash chromatography 
was performed using 75% acetonelhexanes to yield a mixture of 64a and 64b 
( 11.7 mg, 41%) as a white solid. The yield based on recovered starting material 
was 56%. Flash chromatography was preformed on the mixture using 50% 
acetoneJhexanes to yield 64a (3 .4 mg) and 64b (7 .1 mg). Physical data for 
compound 64a: mp 160-162°C. IR (CC14) vmu 3196 (m), 3088 (m), 2967 (s), 
1712 (s), 1659 (s) em·'. 1H NMR (CDC13): 6 5.91 (1H, b s, H-1), 2.68 (4H, s, H-3 
and H-4), 2.16 (2H, m, H-7 and H-11, equatorial), 1.58 (4fL m, H-8 and H-10), 
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1.32 (2H, m, H-7 and H-11, axial), 1.02 (1H, m, H-9), 0.87 (914 s, H-2', H-3', and 
H-4'}. 13C NMR (CDC13): ~ 208.0 (0, C-5), 171.8 (0, C-2), 61.7 (0, C-6), 46.9 (1, 
C-9), 37.5 (2, C-7 and C-11), 35.1 (2, C-3 or C-4), 32.6 (0, C-1'), 29.3 (2, C-3 or 
C-4), 27.7 (3, C-2', C-3', C-4'), 23.4 (2, C-8 and C-10}. MS mlz (%): 238 (3), 209 
(58), 194 (30), 154 (24), 153 (19}, 152 (26). 
trllns-1-Aza-9-t~trt-butylspiro[S.S]undecane-2.5-dione (64b) 
l' 
J' 
64b 
0 White solid: mp 230-233°C. IR (CC14) vmax 3193 (m), 2933 
(m), 1722 (m), 1660 (m) em·•. 'H NMR (CDC13): ~ 6.12 (lH, b 
s, H-1), 2.69 (4H, m, H-3 and H-4), 1.78 (6H, m, H-8 or H-10, 
H-7, and H-11), 1.11 (3H, m, H-8 or H-10, H-9}, 0.87 (9H, s, 
H-2', H-3', and H-4'). 13C NMR (CDCI1): ~ 208.6 (0, C-5), 
171.1 (0, C-2), 63.5 (0, C-6), 47.0 (1, C-9), 35.1 (2, C-3 or C-
4), 35.0 (2, C-7 and C-11), 32.7 (0, C-1'), 29.2 (2, C-3 or C-4), 
27.6 (3, C-2', C-3', C-4'), 21.7 (2, C-8 and C-10). MS mlz (%): 238 (1), 209 (63, 
M• - CO), 194 ( 41 ), 154 (30), 153 (20), 152 (28), 13 8 (25), 125 (57), 110 (59), 
100 (14), 97 (33), 96 (61), 95 (10}, 82 (20}, 81 (IS), 74 (12), 70 (15), 69 (100), 67 
(14), 57 (8)'t 55 (31), 54 (23, 43 (20), 42 (11), 41 (54), 29 (31), 28 (31), 28 (43), 
27 (15). HRMS calcd for C 14H23N02: 237.1728; found: 237.1698. 
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l-Aza-9-ten-butyl-4,4-dimetbylspiro(S.S]undecaae-2,5-dioae (66) 
I" 
l" A solution ofNH20S03H (370 mg, 3.27 mmol) and 65 (542 
0 
J• 
mg, 2.16 mmol) in 98% formic acid (5.4 mL) was heated 
under reflux for 20 hours. The mixture was cooled to ~ then 
in an ice bath which was followed by the addition of H20 (25 
mL). The mixture was adjusted to~ pH of9-10 using 20% 
NaOH. Workup consisted of extracting with CHC13 (4 x 50 
mL) and drying the combined organic extracts over anhydrous 
MgS04 • The solution was concentrated under vacuum. Flash chromatography 
was performed using 100/o acetonelhexanes to yield 66 (306 mg, 54%) as a beige 
solid: mp: 251-253°C.IR (Nujol) vmu 3213 (m), 3091 (m), 1712 (s), 1666 (s) em·•. 
1H NMR (CDC13): () 6.35 Oa b s, H-1), 2.53 (2H, s, H-3), 1.84-1.70 (8H .. m, H-7 .. 
H-11, H-8 and H-10), 1.20 (6H, s, H-1 "and H-2"), 1.12 (lH, m, H-9), 0.87 (9H, s, 
H-2', H-3' and H-4'). 13C NMR(CDC13): 6 212.8 (0, C-5), 170.3 (0, C-2), 63.1 (0, 
C-6), 46.7 (1, C-9), 43.0 (2, C-3), 42.6 (0, C-4), 35.6 (2, C-7 and C-11), 32.7 (0, 
C-1'), 27.6 (3, C-2', C-3' and C-4'), 24.9 (3, C-1'' and C-2"), 21.7 (2, C-8 and C-
10). MS m/z (%): 250 (7, ~-Me), 237 (58), 222 (17), 180 (12), 154 (77), 153 
(35), 138 (73), 112 (11), 97 (43), 96 (49), 83 (19), 82 (23), 81 (13), 70 (12), 69 
(57), 67 (12), 57 (98), 56 (46), 55 (48), 54 (29), 53 (12), 43 (22), 42 (14), 41 
(100), 39 (19), 29 (42), 28 (23), 27 (15). HRMS calcd forC1JI27N02: 250.1806 
~-Me); found: 250.1825. 
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General Procedure for Beckmann Rearrangement using MSH. Compounds 
77, 107, and 120 were prepared using the method ofTamura and co-workersl5 
with some modifications. The MSH was prepared using the method Tamura and 
co-workers, 34 and the reagent was stored below 0°C. 
l-Aza-6-(3-butenyl}6-isobutyl-4,4-dimethyl-2,5-eyclohe:sadione (77) 
1" 
l"' 
A solution of72 (318 mg, 1.49 mmol) in CH2Cl2 (1.0 
m.L) was added to solution of76 (188 mg, 0.798 
mmol) in CH2Cl2 (1.6 mL) at OOC. The mixture was 
1' A ... 
stirred at this temperature for 20 minutes, warmed to rt 
"" J " 77 overnight and then heated under reflux for 6 hours. 
BF3•Etz0 (0.30 ml) was added, and the mixture was heated under reflux for 30 
minutes. Aqueous workup consisted of washing with saturated NaHC03{aq) (2 x 10 
mL), back-extracting aqueous layers with CH2Cl2 (3 x 10 mL), and drying the 
combined organic layers over anhydrous MgS04 • Flash chromatography was 
performed using 25% acetonelhexanes to yield 77 (97.9 mg, 49%) as a white 
solid. The ratio of76 to 77 in the crude mixture as determined by 1H NMR 
spectroscopy was 0.5:1. mp 69-71°C. IR (CC14} vmax 3198 (m), 3083 (m), 2961 
(m), 1718 (s), 1673 (s) cm·1• 1H NMR(CDC13): 6 6.64 (lH, ~ H-2), 5.73 (lH, m, 
H-3'), 4.99 (2H, m, H-4'), 2.53 (2H, ~ H-6), 2.08 (1H, m, H-2'), 1.98-1.75 (2H, 
m, H-2\ H-1'), 1.71-1.59 (lH, m, H-1"), 1.54-1.43 (2H, m, H-1', H-1"), 1.29 (IH, 
~ H-2"), 1.22- 1.19 (6H, dd, J= 3.9 ~ 11.1 ~ H-1· and 2·), 0.96- 0.94 (3H, 
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dd, J= 1.4 ~ 6.6 Hz, H-3" or4"), 0.91-0.88 (3H, dd,J=4.3 Hz, 6.9 Hz, H-3" 
or 4"). 13C NMR (CDC13): 6 212.6, 212.3 (0, C-4), 171.1 (0, C-1), 137 2 (l, C-3'), 
115.9, 115.8 (2, C-4'), 67.8, 67.6 (0, C-3), 48.2, 48.1 (2, C-1"), 43.4 (2, C-6), 42.4, 
42.3 (0, C-5), 40.0 (2, C-1'), 39.2 (2, C-1'), 28.5 (2, C-2'), 26.3 (2, C-2'), 25.5 (2, 
C-2'), 26.3. 25.5 (3, C-1"' or 2"'), 25.54, 25.50 {3, C-1· or 2·), 25.4 (3, C-4" or 3"), 
24.9, (3, C-4" or 3"), 24.8 (3, C-4" or 3"), 24.5 (2, C-1'), 23.1 (2, C-1'), 14.1 (2, C-
2"). MS m/z (%): 223 (15, ~-CO), 196 (12), 182 (37), 180 (11), 142 (15), 140 
(71 ), 124 (18), 112 (12), 98 (15), 97 (31), 96 (33), 84 (16), 83 (26), 82 (28), 57 
(60), 56 (46), 55 (54), 53 (14), 43 (43), 42 (32), 41 (100), 40 (10), 39 (40), 29 
(55), 28 (28), 27 (42). 
1-Aza-6-(3-batenyl)-6-metbyl-2,5-cyclobexadione (107) 
A solution ofn (316 mg, 1.45 mmol) in CH2CI2 (1.2 
mL) was added to asolutionoflOO (188 mg, 1.13 
I" r 
1
' : "' mmol) in CH2Cl2 (2.3 mL) at OOC. The mixture was 
107 
stirred at this temperature for 10 minutes then at rt 
overnight. BF3•E~O (0.42 mL) was added, and the mixture was stirred at rt for 
3.5 hours, followed by heating to reflux for 3.5 hours. Aqueous workup consisted 
of washing with saturated NaHC03(aq) (2 x 10 m.L), extracting the combined 
aqueous layers with CH2Cl2 (3 x 20 mL) and drying the organic solutions over 
anhydrous MgSO,. The solvent was removed under reduced pressure. Aash 
chromatography was performed using 500/o acetonelhexanes to yield 107 (127.8 
84 
mg, 62%) as a white solid: mp 115-ll'r'C. IR (CCI4) vmax 3195 (bs), 1729 (s), 
1674 (s) em·'. 'H NMR (CDC13): 6 (labs, H-2), 5.75 (lH, ~ H-3'), 5.06 (2H, 
m, H-4'), 2.68 (4H, ~ H-5 and H-6), 2.62 (lH, ~ H-1'), 2.13 (2H, m, H-1' and H-
2'), 1.59 (I H.~ H-2'), 1.38 (3H, s, H-1 "). 13C NMR. (CDC13): 6 208.6 (0, C-4), 
172.0 (0, C-1), 137.1(1, C-3'), 115.8 (2, C-4'), 642 (0, C-3), 39.7 (2, C-1 '), 35.4 
(2, C-5 or C-6), 29.1 (2, C-5 or C-6), 28.5 (2, C-2'), 27.2 (3, C-1 "). MS mlz (%): 
181 (0.2, ~). 153 (34, ~-CO), 138 (12), 126 (31), 112 (25), 98 (100), 97 (48), 
96 (30), 82 (37), 81 (13), 57 (24), 56 (22), 55 (20), 42 (58), 41 (25), 39 (15), 29 
(10), 28 (33}, 27 (22). 
(JS, 4S)-1-Aza-6-(3-butenyi)-S·[(tert-butyldimethylsilyl)oxy)+metbyl-2-
cyc:lobesanone (120) 
1" 
s" \ • .,.....o ~ \ I"' 
4:' r •" 120 
J" 
I' 
A solution of72 (760 mg, 3.53 mmol) in 
CH2Cl2 (1.70 mL) was added to a solution 
~4' of 119 (436 mg, 1.54 mmol) in CH2Cl2 (3.1 
3' 
mL) at 0°C. The mixture was stirred at this 
temperature for 20 minutes than at rt 
overnight. BF3·E~O (0.60 mL) was added, and the mixture was stirred at rt for 1 
hour. Workup consisted of adding 20 mL ofCH2C12 and washing the mixture 
with saturated NaHC03 (2 x 25 mL), extracting with ethyl ether (3 x 25 mL) and 
drying the combined organic layers over anhydrous MgS04• The solution volume 
was reduced to approximately I 0 mL. The resultant solution was passed through 
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a short pad (1.5 em x 2.0 em) ofDOWEX 1 x 8-400 ion exchange res~ strongly 
basic anion and flushed with an additional 75 mL of ethyl ether. The solvent was 
removed under vacuum. Flash chromatography was performed using 50% ethyl 
acetatelhexanes to furnish 120 (279 mg, 60%) as a white solid: mp 67-69°C. IR 
(CCI4) vmu 3136 (m), 2956 (m), 1662 (s) em·'. 1H NMR (CDC13): 6 6.49 (1H, b s, 
H-2), 5.81 (lH, m, H-3'), 5.02 (2H, m, H-4'), 3.72 (1H, t, J= 5.6 Hz. H-4), 2.54 
(IH, m, H-6), 2.35 (lH, m, H-6), 1.93 (2H, m, H-2'), 1.77 (2H, m, H-5), 1.73 (1H, 
m, H-1'), 1.57 (lH, m, H-1'), 1.20 (3H, s, H-1•), 0.90 (9H, s, H-3", H-4" and H-
5"), 0.10 (6H, s, H-1" and H-2"). IJC NMR (CDC13): 6 171.4 (0, C-1), 138.4 (1, 
C-3'), 115.0 (2, C-4'), 72.3 (1, C-4), 58.4 (0, C-3), 36.2 (2, C-1 '), 27.8 (2, C-6 and 
C-2'), 26.3 (3, C-1"'), 25.9 (3, C-3", C-4" and C-5"), 25.4 (2, C-5), 18.2 (0, C-6"),-
3.9 (3, C-1" or C-2"), -4.9 (3, C-1" or C-2"). MS m/z (%): 297 (2, ~). 256 (28), 
242 (44), 240 (40), 198 (37), 115 (33), 111 (10), 110 (13), 101 (25), 99 (11), 98 
(24), 96 (13), 82 (16), 75 (100), 74 (35), 73 (98), 59 (34), 58 (46), 57 (27), 55 
(20), 43 (15), 42 (18), 41 (37), 39 (11), 29 (29), 27 (12). HRMS calcd for 
C1Ji31N02Si: 297 2122; found: 297 2115. 
General Procedure for Electropbilic Cyclization. Compounds 87, 88, and 121, 
were prepared based on the method of Knapp and co-workers.31 
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(6R* ,9R*)-l-Aza-9-(iodomethyl)-6-isobutyl-4,4-dimethylbieyclo[4.3.0]aoaane 
2,5-dioae (87) 
I' Triethylamine (0.21 mL, 2.9 mmol) and TMS-OTf 
I 
(0.50 mL, 2.9 mmol) were added to a stirred solution of 
I'" 
• 77 (238 mg, 0.948 mmol) in pentane (1.4 mL) at 0°C. 
0 ·x J• The solution was stim:d for 20 min at rt, after which 
87 .... 
time the two layers were allowed to separate. The top 
layer was cannulated into a 10 mL round bottom flask, and the oily residue was 
washed with dry pentane (2 x 1 mL). The pentane extracts were concentrated 
under reduced pressure. The residue was cooled in an ice bath and iodine (0.53 g, 
2.1 mmol) in THF (2.1 mL) was added. The reaction mixture was stirred for 10 
minutes. The mixture was removed from the ice bath and quenched with 
saturated sodium sulfite (3.5 mL), and saturated sodium bicarbonate (3.5 mL). 
Workup consisted of extracting with ethyl acetate (3 x 15 mL), washing the 
combined organic layers with saturated sodium bicarbonate (25 mL) and drying 
over anhydrous MgS04• The solvent was removed under vacuum. Flash 
chromatography was performed using 30% ethyl acetatelhexanes to yield a 
mixture of87 and 88 in a4.8:1 ratio. (218.4 mg, 61%) as a beige solid. It was 
possible to isolate a small amount of the two diastereomers. The physical data for 
compound 87 is as follows: mp 83-85°C. IR (CCI4) v.,._ 1712 (s), 1654 (s) em·•. 
1H NMR(CDC13): a 4.25 (lH, m, H-9), 3.67 (lH, d~J= 2.7, 9.7 ~ H-1'), 3.43 
87 
(lH, dd,J= 8.4, 9.7 Hz, H-1'), 2.84 (llL d, J= 16.6 Hz, H-3), 2.49 (lH, d,J= 
16.6 Hz, H-3), 2.16 (2H, ~ H-8) 1.98 (2H, m, H-7), 1.66 (3H, m, H-1" and H-
2"), 1.25 (3H, s, H-1·or 2•), 122 (3H, s, H-1· or 2j, 0.95 (3H, d, J = 6.3 Hz, H-
3" or H-4"), 0.87 (3H, d, J= 6.2 Hz, H-3" or H-4"). 13C NMR (CDC13): 6 213.0 
(0, C-5), 167.0 (0, C-2), 73.8 (0, C-6), 57.6 (1, C-9), 45.3 (2, C-1"), 44.9 (2, C-3), 
42.5 (0, C-4 ), 31.2 (2, C-8), 28.0 (2, C-7), 27.8 (3, C-1· or C-2•), 26.0 (3, C-1· or 
C-2-), 24.8 (3, C-3" or C-4"), 24.6 (3, C-3" or C-4"), 24.1 (1, C-2"), 8.6 (2, C-1'). 
MS mlz (%): 349 (68, ~-CO), 320 (41), 306 (11), 292 (12), 266 (65), 265 (29), 
250 (24), 223 (63), 222 (11), 178 (9), 138 (40), 97 (11), 96 (26), 95 (11), 83 (43), 
82 (88), 80 (12), 67 (10), 58 (11), 57 (20), 56 (66), 55 (77), 54 (17), 53 (20), 43 
(56), 42 (21), 41 (100), 40 (12), 39 (37), 29 (49), 28 (49), 27 (36). 
(6R* ,9S*)-l-Aza-9-(iodometbyl)-6-isobutyl-4,4-dimetbylbicyclo(4.3.0Jnonane 
2,5-dione (88) 
0 1• Beige solid: mp 75-77°C. IR (CC14) vmu 1718 (s), 1639 
r--1 (s) cm·1• 1H NMR (CDC13): 6 4.36 (IH, m, H-9), 3.85 
: (IH, dd, J= 3.6, 9.1 Hz, H-1'), 3.06 (1H, dd, J= 9.1, 
• l" 
1
'" 0 'X 10.1 Hz, H-1'), 2.79 (I H. d, J= 15.1 Hz, H-3), 2.39 
"" 88 (lH, d, J= 15.7 Hz, H-3), 2.23 (IH, m, H-8), 2.08 (2H, 
m, H-7), 1.92 (2H, m, H-8 and H-1"), 1.61 (2H, m, H-2" and H-1"), 1.19 (3H, s, 
H-1· or H-2·), 1.12 (3H, s, H-1· or H-2·), 0.92 (3H, d,J=6.3 Hz, H-3" orH-4"), 
0.89 (3H, d,J=6.3 Hz, H-3"orH-4"). llC NMR(CDC13): 6 213.5 (0, C-5), 167.0 
88 
(0, C-2),. 74.3 (0, C-6), 60.1 (1, C-9), 47.8 (~ C-1 "), 43.9 (2, C-3), 42.4 (0, C-4), 
36.7 (2, C-7),. 29.6 (2, C-8), 26.2 (3, C-1"' or C-2"'), 24.9 (1, C-2"), 24.6 (3, C-4" or 
C-3"), 24.6 (3, C-3" orC-4"), 24.3 (3, C-1"' orC-2"'), 9.9 (2, C-1'). MS mlz(%): 
349 (52, M•- CO), 320 (11), 266 (55), 265 (24), 250 (21), 223 (55), 222 (10), 138 
(34), 97 (9), 96 (22), 83 (30), 82 (81), 80 (11), 68 (10), 67 (10), 57 (19), 56 (62), 
55 (72), 54 (17), 53 (19), 43 (31), 42 (20), 41 (100),. 40 (11), 39 (34), 29 (46), 28 
(30), 27 (33). HRMS calcd for C15H24IN02: 349.0904 (M'"- CO); found: 
349.0915. 
(6S,SS,9S)-1-Aza-S-[(tert-butyldimetbylsilyl)osyJ-9-(iodomethyl)-6-metbyl-
bicyelo[4.3.0)nonaa-2-one (121) 
Triethylamine (0.18 mL, 1.3 mmol) and TMS-OTf (0.23 
1 
mL, 1.3 mmol) were added to a solution of 120 ( 17 4 mg, 
0.584 mmol) in pentane (0.9 mL) at 0°C. The reaction 
mixture was stirred at rt for 30 minutes after which time the 
two layers were allowed to separate. The top layer was 
cannulated into a 10 mL round-bottom flas~ and the oily 
residue was washed with dry pentane (2 x 1 mL ). The 
pentane extracts were concentrated under reduced pressure. The residue was 
cooled in an ice bath, and a solution of iodine (0.33 g, 1.30 mmol) in THF (1.3 
mL) was added. The mixture was stirred at this temperature for 10 minutes, 
removed from the ice bath and quenched with saturated sodium sulfite (2.2 mL), 
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followed by saturated sodium bicarbonate (2.2 mL ). The reaction mixture was 
extracted with ethyl acetate (3 x 20 mL) and dried the combined organic layers 
over anhydrous MgS04• The volume ofthe solution was reduced under vacuum. 
Flash chromatography was performed using 30% ethyl acetatelhexanes to yield 
121 (34.6 mg, 14%) and a fraction containing 121 and its isomer (39.8 mg, 16%) 
in a ratio of4.2:1. Compound 121 was a beige solid: mp 128-12~C. IR (CC14) 
vmax 2956 (m), 1648 (s) cm·1• [cx)o24 = -6.5°, c·= 3.51 mglmL in MeOH. 1H NMR 
(CDC13): 6 4.04 (lH, m, H-9), 3.82 (2H, ~ J= 9.1 Hz, H-1'), 3.79 (lH, m, H-5), 
3.23 (lH, t, J= 9.0 Hz, H-1'), 2.44 (1H, m, H-3), 2.32 (lH, m, H-3), 2.24-2.08 
(3H, m., H-8, H-7 and H-4), 1.81 (IH, m, H-4), 1.74 {lH, m, H-8), 1.45 (1ft m, 
H-7), 1.26 (3H, s, H-1 .. ), 0.87 (9H, s, H-4", H-5" and H·6"), 0.08 (3H, s, H-2" or 
H-1 "), 0 .06 (3H, s, H-1" or H-2"). 13C NMR (CDC13): 6 170.5 (0, C-2), 70.4 (1, 
C-5), 67.6 (0, C-6), 59.7 (1, C-9), 32.9 (2, C-7), 29.5 (2, C·8), 27.2 (3, C-1·), 26.8 
(2, C-3), 26.2 (3, C-4", C-5", and C-6"), 25.5 (2, C-4), 18.5 (0, C-3"), 12.5 {2, C-
1'), -4.1 (3, C-1" or C-2"), -4.6 (3, C-1" or C-2"). MS mlz (%): 423 (6, ~), 366 
(19), 366 (100), 296 (21), 292 (33), 265 (24), 224 (31), 223 (16), 164 (10), 150 
(11), 122 (13), 115 (44), 108 (10), 101 (32), 98 (33), 96 (30), 82 (12), 75 (45), 73 
(58), 59 (27), 57 (21), 56 (11), 55 (24), 42 (15), 41 (36), 39 (ll), 29 (23), 27 (10). 
HRMS calcd for C16H310 2INSi: 423.1091; found: 423.1091. 
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General Procedure for the NucleopbUic Substitution using Cesium 
Propionate. 
Compounds 89,. 90., 122, and i23 were prepared based on the method of Shieh and 
Prestwich.39 
(6R* ,9R*)-l-Aza-9-(bydroxymetbyl}-6-isobutyl-4,4-dimetbyl-
bicyclo[4.3.0)nonane-2,5-dione, propyl ester (89) 
1'" 
. 
o• 
l 
0 
Cesium propionate (28.0 mg, 0.136 mmol) 
I' I in DMF ( 1.4 mL) was added to a solution O~"' 
of87 (48.0 mg, 0.127 mmol) in DMF (1.3 
mL). The reaction mixture was stirred at rt 
for 2 hours, heated under reflux for 4 hours, X- l" 
89 "" 
and then stirred at rt overnight. Aqueous 
workup consisted of washing the organic layer with brine (25 mL) and extracting 
with CH2Cl2 (3 x 50 mL). The combined organic layers were dried over 
anhydrous MgS04 • The solution was concentrated under reduced pressure. Flash 
chromatography was performed using 30% ethyl acetatelhexanes. Further 
purification was required using 50 % acetonelhexanes to yield 89 ( 16.4 mg, 40%) 
and 90 (20.6 mg, 60%). Compound 89 was a pale yellow residue: IR (CC14) vmax 
2960 (m), 1740 (s), 1719 (s), 1662 (s) cm·1• 1H NMR (CDC13): 6 4.53 (IH, dd, J= 
4.5, 11.2 Hz, H-1'), 4.32 (2H,. m, H-1' and H-9), 2.86 (lH, d,J= 16.5 ~ H-3), 
2.43 (lH, d, J= 16.5 Hz, H-3), 2.27 (2H, q, J= 7.3 Hz, H-3'), 2.13 (JH, m, H-8 
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and H-7), 1.84 (lH, m, H-7), 1.68 (3H, m, H-2" and H-1"), 1.23 (3H, s, H-1"' or 
H-2"'}, 1.17 (3H~ s, H-1"' or H-2j, 1.09 (3H, t, J = 7.8 Hz, H-4'), 0.95 (3H, d, J = 
6.2 Hz. H-4" or H-3"), 0.88 (3H, d, J= 6.1 Hz, H-3" or H-4"). 13C NMR (CDC13): 
6 213.6 (0, C-5), 174.2 (0, C-2'), 168.9 (0, C-2), 73.4 (0, C-6), 63.3 (2, C-1'), 56.0 
(1, C-9), 45.7 (2, C-1"), 45.0 (2, C-3), 42.6 (0, C-4), 32.6 (2, C-8), 27.7 (2, C-3'), 
26.9 (3, C-1"' or C-2j, 25.8 (3, C-1"' orC-2"'), 25.7 (2, C-7), 24.9 {1, c..:2"), 24.7 
(3, C-4" or C-3"), 24.2 (3, C-4" or C-3"), 9.2 (3, C-4'). MS mlz (%): 295 (15, ~-
CO), 252 (13), 212 (65), 211 (26), 210 (48), 196 (23), 180 (15), 169 (21), 156 
(12), 96 (15), 97 (29), 84 (11), 83 (30), 82 (75), 57 (66), 56 (37), 55 (44), 43 (12), 
41 (64), 39 (19), 29 (100), 28 (13), 27 (31). 
(6R* ,9R*)·l-Aza-9-(hydroxymetbyl)-6-isobutyl-4,4-
dimetbylbieyclo(4.J.O) aoaaae-2,5-dioae (90) 
I' 
- l" 
l"' .~ 
0 1"" 90 .. " 
Beige solid: mp 80-82°C. IR (CC14) vmu 3426 (bm), 
OH 2962 (m), 1721 (s), 1644 (s) em·•. 1H NMR (CDC13): 
6 4.67 (IH, m, -OH), 4.16 (lH, m, H-9), 3.74 (2H, 
m, H-1'), 2.87 (lH, d, J= 16.5 Hz, H-3), 2.49 (lH, 
d, J = 16.5 Hz, H-3), 2.09 (2H, m, H-8}, 1.64 (5H, m, 
H-7, H-1" and H-2"), 1.23 (3H, s, H-1"' or 2"'), 1.19 (3H, s, H-2"' or H-1"'), 0.95 
(3H, d, J=6.2 Hz. H-3" and H-4"), 0.88 (3H, d, J= 6.2 Hz. H-3" or H-4"). 13C 
NMR (CDC13): 6 213.0 (0, C-5), 170.8 (0, C-2), 74.3 (0, C-6), 66.5 (2, C-1 '), 62.2 
(1, C-9), 45.7 (2, C-7 or C-1 "), 44.8 (2, C-3), 42.0 (0, C-4), 32.7 (2, C-8), 26.9 (3, 
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C-1"' or C-2·), 26.3 (2, C-7 orC-1"), 25.6 {3, C-1· orC-2•), 24.9 (1, C-2")., 24.7 
(3, C-3" or C-4"), 24.3 (3, C-3" or C-4"). MS mlz (%): 249 (4, M"- H20), 239 
(24), 234 (14), 210 (27), 196 (13), 182 (14), 180 (30), 178 (32), 156 (62), 155 
(24), 140 (22), 138 (14), 125 (10), 124 (23), 113 (39), 112 (16), 97 (10), 96 (19), 
95 (27), 94 (10), 86 (12), 84 (13), 83 (77), 82 (97), 81 (12). 80 (12), 69 (16), 68 
(18), 67 (15), 60 (12), 57 (31), 56 (49), 55 (77), 54 (15), 53 (18), 45 (22), 44 (41), 
43 (64), 42 (28), 41 (100), 40 (12), 39 (34). HRMS calcd for C15H25N03N: 
239.1833 (~-CO); found: 239.1855. 
(6S,SS~S)-1-Aza-S-[(tert-butyldimetbylsilyl)oxy)-9-(hydroxymethyl)-6-
methylbieyclo(4.3.0Jnonan-2-oae, propyl ester (123) 
0 
0 4
, Cesium propionate (30 mg, 0.15 mmol) in DMF 
1• Y (0.10 mL) was added to a solution of 121 (28.3 ro 
mg, 0.0667 mmol) in DMF (0.63 mL). The 
mixture was stirred at rt for 14 hours., heated to 
0 .... 
I 123 
reflux for 2 hours and then stirred at rt overnight. 
1~*·~· Aqueous workup consisted of washing the organic layer with brine (15 mL), then back-
5" 
extracting the aqueous layer with CH2Cl1 (3 x 15 
ml). The combined organic extracts were dried over anhydrous MgS04• The 
volume of the solution was reduced under vacuum. Flash chromatography was 
performed using 30% ethyl acetatelbexanes to produce Ill (8.0 mg, 32%) and 
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Ill (11.5 mg, 58%). Compound 123 was a beige solid: mp 71-74°C. IR (CCI4) 
vmu 2956 (m), 1742 (s), 1644 (s) em·•. 1H NMR. (CDC13): 6 4.37-4.26 (3H, m, H-
I' and H-9), 3.83 (lH, m, H-5), 2.45 (1H, m, H-3), 2.33 (3H, m, H-3', H-3), 222-
2.08 (2H, m, H-4 and H-7), 2.02 (l H, m, H-8), 1.82 (2H, m, H-4 and H-8), 1.46 
(lH, m, H-7). 121 (3H, s, H-t•), 1.14 (3H, t, J= 1.4 Hz, H-4'), 0.87 (9H, S, H-4". 
H .. 5" and H-6"), 0.08 (3H, s, H-1" or H-2"), 0.07 (3H, s, H-1" or H-2"). nc NMR 
(CDCh): c5 174.5 (0, C-2'), 170.1 (0, C-2), 70.0 (1, C-5), 66.8 (0, C-6), 65.3 (2, C-
1'), 57.2 (1, C-9), 33.0 (2, C-7}, 27.8 {2, C-3'), 26.5 (2, C-3), 262 (3, C-t•), 26.0 
(3, C-4", C-5", C-6"), 25.3 (2, C-4), 24.5 (2, C-8), 18.3 (0, C-3"), 9.4 (2, C-4"},-
4.3 {3, C-1" or C-2"), -4.8 (3, C-1" or C-2"). MS mlz (%): 369 (5, ~). 313 ( 19), 
312 (76), 295 (14), 283 (22). 282 (100), 256 (12), 239 (13), 238 (63), 211 (17), 
198 (10), 183 (18), 182 (12). 170 (54), 169 (36), 164 (45), 162 (12), 154 (18), 150 
(56), 137 (29), 136 (12), 131 (22), 126 (24), 122 (30), 116 (11), 115 (69), 114 
(11), 112 (18), 110 (10), 109 (12), 108 {34). 101 {44), 97 {12), 96 (60), 95 (41), 94 
(17), 85 (11), 83 (13), 82 (26), 81 (14), 75 (63), 74 (10), 73, {91), 69 {1), 59 (32), 
57 (57), 56 {12), 55 (43), 43 (11), 42 (12), 41 (30), 29 (60), 28 (21), 27 (10). 
HRMS calcd for C 11H350 4NSi: 369.2333; found: 369.2326. 
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{6S,5S)-l-Aza-S-((tert-butyldimethylsilyl)oxy)-6,9-dimethylbicyclo{4.3.0)non-
8-en-Z-oae (lll) 
Beige solid: mp 74-76°C. IR (CCI4) v_ 2929 (m), 1670 (s) 0 I' 
0 I"' (IH, m, H-3), 2.25 (3H, m, H-1'), 2.10 (1H, m, H-7), 1.83 
I 
l~Si- t" (2H, m, H-7 and H-4), 1.21 (3H, s, H-1-), 0.87 (9H, s, H-4", 
~·· Ill 
6tt" 1"' "" H-5" and H-6"), 0.08 (3JL s, H-1" or H-2"), 0. 78 (3 H, s, H-1" 
5" 
or H-2"). 13C NMR (CDCl3): 6 168.4 (0, C-2), 140.9 (0, C-9), 
106.9 (1, C-8), 69.5 (1, C-5), 68.8 (0, C-6), 38.0 (2, C-4), 27.4 (2, C-7), 25.7 (3, 
C-1·), 25.9 (3, C-4", C-5" and C-6"), 25.7 (2, C-3), 18.3 {0, C-3"), 17.3 (3, C-1'),-
4.1 (3, C-1" orC-2"), -4.8 (3, C-1" orC-2"). MS mlz (%): 295 (29, M•), 239 (17), 
238 (80), 164 (16), 162 (15), 148 (28), 137 (23), 120 (11), 115 (71), 109 (25), 108 
(24), 101 (40), 97 (18), 96 (99), 95 (100), 94 (25), 85 (11), 75 (53), 73 (64), 59 
(47), 57 (17), 55 (11), 54 (11), 53 (10), 42 (12), 41 (28), 39 (12), 29 (21). HRMS 
calcd for C 1Jf290 2NSi: 295.1966; found: 295.1955. 
General Procedure for tbe Formation of Reductive Succinoylatioa Products. 
Compounds 102 and lOS were produced as by-products using the method of 
Curran and co-workers_42."3 
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(~)-2-Hydroxyethyl-5-isobutyl-4-oxoaoaanoate (102) 
Compound 101 (188 mg, 1.02 mmol) was 
9 
dissolved in CH2Cl2 (10.2 mL) and cooled to-
dropwise over 2 hours, and, after ten minutes, 1 
~- (304 mg, 1.32 mmol) was introduced slowly. The mixture stined at -78°C for 3 hours and then 
OH 
warmed to soc slowly . After ten minutes, the 
reaction was diluted with EtzO (20 mL), followed by H20 (20 mL). The mixture 
was extracted with EtzO (3 x 25 mL). The combined organic extracts were 
washed with brine (50 mL) and dried over anhydrous MgS04• Flash 
chromatography was performed eluting with 20% ethyl acetate/hexanes to yield 
102 (133 mg, 48%) as a yellow liquid: IR vnwt 3459 (b s), 2956 (m}, 1737 (s) em·•. 
1H NMR (CDC13): 6 5.76 (1H, m, H-8), 4.99 (2H, m, H-9), 4.24 (2H, m, H-1·), 
3.82 (2H, m, H-2·), 2.79 (2H, t, J= 6.0 ~ H-3), 2.60 (3H, m, H-2 and H-5), 2.02 
(2H, m, H-7), 1.72 (2H, m, H-6), 1.50 (2H, m, H-2' and H-1 '), 1.23 (1H, m, H-1 '), 
0.89 (6H, apparent t, J= 6.3 Hz, H-3' and H-4'). 13C NMR (CDC13): 6 213.3 (0, 
C-4), 173.3 (0, C-1), 138.3(1, C-8), 115.4 (2, C-9), 66.4 (2, C-1 "), 61.2 (2, C-2"), 
49.3 {2, C-2), 41.1 {2, C-1'), 37.1 (2, C-3), 31.6 (2, C-1), 31.2 (2, C-6), 27.9 (1, C-
5), 26.1(1, C-2'), 23.1 (3, C-3' or C-4'), 22.6 (3, C-3' or C-4'). MS mlz (%): 270 
(1, M"), 198 (11), 173 (24), 155 (57), 154 (13), 153 (12), 145 {16), 111 (97), 101 
96 
(100), 85 (12), 83 (22), 69 (52), 57 (19), 56 (13), 55 (45), 45 (26), 43 (33), 41 
{36), 32 (12), 29 {19), 28 (47), 27 (13). HRMS calcd for C,5H260 4: 270.1829; 
found: 270.1803 
Methyl (:i:)-5-isobutyl--4-oxononanoate (lOS) 
6 I 
Compound 104 (356 mg., 1.91 mmol) was 
l' 7 ~ 9 
dissolved in CH2Cl2 (19 mL) followed by the 
lOS addition of sA powdered Molecular Sieves (0.50 
g). The reaction mixture was cooled to -78°C and 
BF3·E~O (2.42 mL., 19.1 mmol) was added 
dropwise. After ten minutes, 1 (572 mg., 2.48 
mmol) was introduced slowly. The reaction mixture was stirred at -78°C for 3 
hours and allowed to warm slowly to 5°C . To the mixture was added with E~O 
(20 mL)., and H20 (20 mL). The aqueous layer was re-extracted with EtzO (3 x 30 
mL). The combined organic extracts were washed with brine (50 mL) and dried 
over anhydrous MgS04• The volume of the solution was reduced under vacuum. 
Flash chromatography was performed eluting with 20% ethyl acetatelbexanes to 
yield 105 (223 mg, 4')0/o) as a colorless liquid: lR vmax 2955 (m), 1742 (s), 1713 (s) 
em·•. 1H NMR (CDC11): 6 5.76 (lH, m, H-8), 5.01 (2H, m, H-9), 3.68 (3H., s., H-
1 "), 2.76 {2H, ~ J= 6.2 Hz, H-3), 2.61 (3H, m, H-2 and H-5), 2.02 (2H, m, H-7), 
1.72 (lH., m, H-6), 1.49 (3H, m, H-6, H-2' and H-I'), 1.21 (lH, m, H-1'), 0.88 (6H, 
apparent~ J= 6.4 Hz, H-3' and H-4'). 13C NMR. (CDC13}: 6 212.6 (0, C-4), 173.4 
97 
{0, C-1), 138.3 (1~ C-8), 115.5 {2, C-9), 51.9 (3, C-1"}, 49.4 {1, C-5), 41.2 {2, C-
1'), 37.0 {2, C-3), 31.7 {2, C-7), 31.3 (2, C-6), 27.8 (2, C-2), 26.2 (1, C-2'), 23.1 
{3, C-3' or C-4'), 22.7 (3, C-3' or C-4'). MS mlz (%): 186 (26), 143 (100), 115 
(99}, Ill (97), 87 (16), 83 (24), 69 (60), 67 (11), 59 (20), 57 (16), 55 (16), 43 
(36), 41 (54), 39 (13), 29 (18}, 27 (19). HRMS calcd for C 14H240 3 : 240.1724; 
found: 240.1704. 
General Procedure for Baker's Yeast Reduction 
Compound 118 was prepared by a procedure based on that of Burnell and Zhu.9 
(2S, 3S) l-(3-Butenyl).3-bydroxy-l-methylcyclopentanedione ( 118) 
I' 
118 
Fleischman's Traditional dry yeast (8.0 g) and sucrose 
(18.0 g) were added to deionized H20 (100 mL). The 
A •· 
l' mixture was agitated in a 32°C bath. After 10 minutes 
a solution oflOO (167 mg, 1.00 mmol) in 95% EtOH 
(3.0 mL) and 0.2% Triton X-100 (12 mL) was added. This suspension was 
agitated for an additional48 hours. Ethyl ether (100 mL) was added and the 
mixture was allowed to stand for 20 hours. The ether layer was decanted, and the 
process was repeated three times with 100 mL of ethyl ether. The combined 
organic layers were washed with brine (150 mL} and dried over anhydrous 
MgS04• Flash chromatography was performed with 50% ethyl acetate/hexanes to 
furnish 118 (58.7 mg, 35%) a yellow liquid and starting material100 (80.1 mg) 
thus the yield based on recovered starting material was 66%. 
98 
IR vmu 3456 (b s), 2967 (m), 1729 (s) em-•. [cxf40 = +62°, C = 0.95 mglm.L 
MeOH. 1H NMR (CDC13): 6 5.85 (lH, m, H-3'), 5.01 (2H, ~ H-4'), 4.13 (lH, t, J 
= 4.5 Hz, H-3), 2.47 (1H, m, H-5), 2.30 (lH, m, H-5), 2.24-2.13 (2H, m, H-4 and 
H-2'), 2.06 (1 H, m, H-2'), 1.96 (1 H, m, H-4), 1.63 (2H, t, J = 8.1 Hz., H-1 '), 1.01 
(3H, s, H-1 "). 13C NMR (CDC13): 6 220.6 (0, C-1), 138.8 (1, C-3'), 115.1 (2, C-
4'), 77.6 (1, C-3), 53.2 (0, C-2), 34.1 (2, C-5), 29.5 (2, C-4), 28.3 (2, C-1'), 28.1 
(2, C-2'), 19.4 (3, C-1 "). MS mlz (%): 168 (1, M'"), 114 (100), 113 (54), 99 (31), 
97 (27), 86 (15), 85 (30), 84 (30), 81 (37), 71 (15), 55 (19), 51 (12), 49 (48), 43 
(39), 41 (36). HRMS calcd forC1ofl160 2 : 168.1149; found: 168.1146. 
General Procedure for Protection of Alcohol. Compound 119 was prepared 
based on the procedure of Corey and Venkateswarlu.47 
(2S, 3S) 2-(3-Butenyl)-3-((tert-butyldimetbylsilyl}oxy)-2-
methylcyclopentanone (119) 
Imidazole ( 170 mg, 2.50 mmol), and then 
l" 
\ 0 
5" Si,.. 
.?(\ 
~ TBS-Cl (200 mg. 1.30 mmol) were added 
""' 4' 
.... l' J' to a solution of 118 ( 189 mg, 1.12 mmol) 119 
l" in DMF (5.0 mL). The mixture was 
stirred for 24 hours at rt. H20 (10 mL) was added, and the mixture was extracted 
with petroleum ether (3 x 15 mL). The combined organic layers were dried over 
anhydrous MgS04 • The volume of the solution was reduced under vacuum. Flash 
chromatography was performed using 20% ethyl acetatelhexanes to yield 119 (199 
99 
mg,. 63%) as a yellow liquid. The yield for this reaction based on recovered 
starting material was 83%. IR vmax 2956 (m), 1741 (s) em·•. 1H NMR (CDC13): .S 
5.79 (IH, m, H-3'), 4.99 {2H, m, H-4'), 4.03 (IH, t,. J= 6.3 Hz, H-3},. 2.40 (IH, m, 
H-5), 2.23 (1H, m, H-5), 2.14-1.87 (4H, m, H-4 and H-2'), 1.66 (IH, m, H-1 '), 
1.51 (IH, m, H-1'), 0.98 (3H, s, H-1'j, 0.89 (9H, s, H-4", H-5", and H-6"), 0.10 
(3H, s, H-1" or H-2"), 0.08 (3H, s, H-1" or H-2"). 13C NMR (CDCI3): 6 220.8 (0, 
C-1), 139.0 (1, C-3'), 114.5 (2, C-4'), 78.4 (l, C-3), 53.4 (0, C-2), 34.4 {2, C-5), 
29.8 (2, C-1'), 28.6 (2, C-2' or C-4), 28.3 (2, C-4 or C-2'), 25.8 (3, C-4", C-5" and 
C-6"), 19.5 (3, C-1"'), 18.2 (0, C-3"), -4.1 (3, C-1" or C-2"), -4.6 (3, C-1" or C-2"). 
MS mlz (%): 241 (15), 225 (M·- tBu, 17), 181 (10), 171 (12), 133 (24), 129 (28), 
107 (25), 105 (11), 101 (33), 91 (11), 75 (100), 73 (80), 59 (18), 55 (10), 41 (21). 
HRMS calcd for C 16H300 2Si: 225.1310 (~ -'Bu); found: 225.1288. 
2-Methyloet·7-en-4-one, ethylene acetal (101) 
Ethylene glycol (3.20 g, 51.5 mmol) and 75 (1.43 g, 
A 
11 
10.2 mmol) were dissolved in 75 mL ofbenzene. A 
5 1 
small spatula-tip of p-TsOH was added, and the 101 
reaction mixture was heated to reflux for 2 days, with azeotropic removal of H20. 
Most of the benzene was removed by distillation and the residue was washed with 
saturated NaHC03 (2 x 50 mL ). The aqueous layer was extracted with CH2Cl2 (3 
x 50 mL) and the combined organic layers were dried over anhydrous MgS04• 
The solvent was removed under reduced pressure to yield 101 (1.87 g, 98%) as a 
100 
colorless liquid: IR vmax 2952 (m). 1H NMR. (CDC13): 6 5.84 (lH, m, H-7), 4.97 
(2H, m, H-8), 3.93 (4H, s, H-1' and H-2'), 2.12 (2H, m, H-6), 1.74 (3H, m, H-2 
andH-5), 1.52(6H,d,J=6.3 Hz, H-I andH-1"). 13CNMR(CDC13):~ 138.9(1~ 
C-7), 114.3 (2, C-8), 111.9 (0, C-4), 64.8 (2~ C-1' and C-2'}, 45.5 (2, C-3), 36.7 (2, 
C-5), 28.3 (2, C-6), 24.3 (1, C-2), 24.2 (3, C-1 and C-1 "). MS mlz (%): 129 (77, 
~-C4H7), 127 (73), 85 (35), 57 (35), 55 (38), 45 (11), 43 (18), 41 (28), 39 (14), 
32 (21), 29 (17), 28 (100), 27 (18). HRMS calcd forCuH200 2: 129.0915 ~-
C4H7); found: 129.0889 
Hex-5-ea-l-one, ethylene acetal (99) 
{\ Ethylene glycol (6.35 g, 102 mmol) was placed in 75 mL of 
~ benzene followed by allyl acetone (1.96 g, 20.0 mmol). A 
99 small spatula-tip of p-TsOH was added and the reaction 
mixture was heated to reflux for 2 days with azeotropic removal of H20. Most of 
the benzene was distilled, and the residue was washed with saturated NaHC03 (2 
x 50 mL ). The aqueous layer was extracted with CH2Cl2 (3 x 50 mL ), and the 
combined organic layers were dried over anhydrous MgS04• The solvent was 
removed under reduced pressure to yield 99 (2.52 g, 890/o) as a colorless liquid: IR 
vmax 2962 (m). 'H NMR. (CDC13): ~ 5.84 (Ia m), 4.98 {2H, m), 3.95 (4H, m), 
2.16 (2H, m), 1.74 (2H, m), 1.33 (3H, s). 13C NMR (CDC13): 6 138.7, 114.4, 
110.0, 64.9, 38.5, 28.5, 24.1. MS m/z(o/o): 127 (15, ~-Me), 87 (100), 55 (22), 
43 (93), 41 (14), 28 (40). 
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2·Methyloct· 7-en-4-one, methyl acetal (104) 
Based on a procedure by Wenkert and Good~ 41 
trimethylorthofonnate (1.90 mL, 17.4 mmol) was 
J 5 7 
added to a solution of75 (485 mg, 3.46 mmol) in 
104 
MeOH (10 mL). A small spatula-tip of p-TsOH 
was added, and the mixtme was heated to reflux for 17 hours. The mixture was 
cooled to rt and diethyl ether (SO mL) was added followed by a 1: 1 mixture of 5% 
NaOH!saturated NaCL The organic layer was washed with brine (50 mL), H10 
(SO mL), and brine (50 mL). The organic layer was dried over anhydrous MgS04 
and the solvent was removed under vacuum to yield 104 (423 mg, 66%) as a 
brown liquid: IR vmu 2955 (m) cm·1• 1H NMR (CDCl3): 6 5.84 (1H, m .. H-7), 
4.99 (2a m, H-8), 3.14 (6H, s, H-1" and H-2"), 2.01 (2H, m, H-6), 1.70 (3H, m, 
H-5 and H-2), 1.50 (2H, d, J= 6.3 Hz, H-3), 0.96 (6H, d, J= 6.1 Hz, H-1 and H-
1'). 13C NMR (CDCI3): 6 138.4 (1, C-7), 114.5 (2, C-8), 103.5 (0, C-4), 47.6 (3, 
C-1" and C-2"), 40.5 (2, C-3), 31.9 (2, C-5), 28.3 (2, C-6), 23.9 (1, C-2), 23.7 (3, 
C-1 and C-1'). 
2-Methyl--oct-7-en-4--one, 1,3-batanediol acetal (106) 
4" l" 
I' 
)r-r( Compound 75 (1.22 g, 8. 70 mmol) and technical grade(±) 2,3-butanediol (4.00 g,. 44.4 mmol) were 
0 0 
dissolved in benzene (35 m.L). A small spatula-tip of 
5 7 106 p-TsOH was added, and the mixture was heated to 
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reflux for 4 days with azeotropic removal of H20. Most of the benzene was 
removed by distillation and the residue was washed with saturated NaHC03 (100 
mL). The aqueous layer was back-extracted using CH2Cl2 (2 x 75 mL). The 
combined organic extracts were washed with brine (100 mL) and dried over 
anhydrous MgS04• The volume of the solution was reduced under vacuum. Flash 
chromatography was performed using 5% ethyl acetatelhexanes. There was some 
difficulty separating 75 from 106~ but a small amount of 106 was isolated (524 
mg, 28%) as a colorless liquid: IR vmu 2955 (s) em·'. lH NMR (CDC13): c5 5.84 
(2H, m, H-7), 4.98 (4H, ~ H-8), 4.25 (2H, m, H-1", H-2" of meso acetal), 3.61 
(2H, m, H-1 ", H-2" of dll acetal), 2.19-2.07 (4H, m, H-6), 1.73 (6H, m, H-2 and 
H-5), 1.53 (4H, m, H-3), 1.23 (6H, d, J= 5.1 Hz, H-3", H-4" of d/1 acetal),. 1.13 
(6H, t, J= 6.0 ~ H-3", H-4" of meso acetal), 0.95 (6H, m, H-1 and H-1'). 13C 
NMR (CDCI3): 6 139.1, 139.0, 138.8 (1, C-7), 114.3 (2, C-8), 111.1, 110.6, 110.3 
(0, C-4), 78.8, 78.5 (1, C-1" and C-2" of d/1 acetal), 73.7, 73.5 {1, C-1" and C-2" 
of meso acetal), 47.3, 46.9, 45.4 (2, C-3), 38.2, 37.3, 36.5 {2, C-5), 29.1, 28.3, 
28.2 (2, C-6), 24.8 (1, C-2), 24.6~ 24.4, 24.3, 24.2, 24.1 (3, C-1 and C-1'), 17.2, 
17.0 (3, C-3" and C-4" of d/1 acetal)~ 16.0, 15.9 (3, C-3" and C-4" of meso acetal). 
MS mlz (%): 157 (64, ~- C4H7), 155 (58), 85 (64), 83 (40), 69 (10), 57 (85), 55 
(100), 43 (23), 41 (38), 39 (12), 29 (29), 28 (30), 27 (16). HRMS calcd for 
C 13H240 2: 157.1228 ~-C4H7); found: 157.1208. 
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General Procedure for the Grignard reaction and Oxidation using PCC. 
Compounds 45 and 75 were prepared based on the method of Newcomb and 
coworkers49 with some modifications. Oxidation using PCC was performed based 
on the method of Corey and Suggs, 50 and the mechanical activation of the 
magnesium turnings was accomplished using the procedure of Baker and 
coworkers. 51 
2-Methylocta-7-ea-4-one (75) 
0 
Magnesium turnings (1.46 g, 59.9 mmol) were stirred 
under an atmosphere of nitrogen for 24 hours. THF ( 40 
mL) was added followed by a solution of4-bromo-1-
butene (4.23 g, 31.3 mmol) in THF (10 mL). The 
mixture was heated to reflux for 2.5 hours, cooled to rt and then in an ice/salt 
bath. A solution ofisovaleraldehyde 73 (3.30 g, 38.3 mmol) in THF (10 mL) was 
added dropwise, and the mixture was stirred at rt overnight. The reaction mixture 
was poured into saturated NH4CI (100 mL). The aqueous layer was extracted 
with diethyl ether (4 x 100 mL). The combined organic layers were dried over 
anhydrous MgS04, and the volume was reduced under vacuum to yield the 
alcohol, which was immediately oxidized to the ketone. A solution of the alcohol 
(4.45 g, 38.3 mmol) in CH2CI2 (10.5 mL) was added to a solution ofPCC (10.7 g, 
49.8 mmol) in CH2Cl2 (52.5 mL). The mixture was stirred at rt for 4.5 hours. The 
solution was decanted from the black precipitate. The precipitate was extracted 
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with diethyl ether (4 x 50 ml). The volume of the solution was reduced to 50 mL 
and the residue was flushed through a Florisil column containing activated 
charcoal to yield 75 (3.84 g, 88%) as a yellow liquid: IR vmax 2957 (s), 1712 (s) 
em·•. 1 H NMR (CDC13): ~ 5.00 ( 1 H, m), 5.81 (2H, m), 2.49 (2H, m), 2.31 ( 4H, 
m), 2.17 (1H, sep.,J= 6.4 Hz), 0.93 (6H, s), 0.91 (3H, s,). 13C NMR(CDC13): 6 
210.0, 137.1, 115.0, 51.8, 42.2, 27.6, 24.5, 22.5. 
l·Phenylpent-4-en-1-one ( 45) 
0 
Magnesium turnings (1.06 g, 43.6 mmol) were stirred 
under an atmosphere of nitrogen for 24 hours. THF 
(30 mL) was added followed by a solution of 4-
bromo-1-butene (4.90 g, 36.3 mmol) in THF (10 
mL). The mixture was heated to reflux for 2.5 hours, cooled ton and then in an 
ice/salt bath. A solution of benzaldehyde 42 (3.93 g, 37.0 mmol} in THF (10 mL) 
was added and the mixture was stirred at n overnight. The reaction mixture was 
poured into saturated NH4Cl ( 100 mL ). The aqueous layer was extracted with 
diethyl ether (4 x 80 m.L). The combined.organic layers were dried over 
anhydrous MgS04 and the volume was reduced to yield the alcohol (5.50, 93%). 
A solution of the alcohol (5.25 g, 32.4 mmol) in CH2C12 (14 mL) was added to a 
solution ofPCC (10.5 g, 48.6 mmol) in CH2Cl2 (65 mL). The mixture was stirred 
at n for 4 hours, and then the solution was decanted from the black precipitate. 
The precipitate was extracted with diethyl ether (4 x 100 mL). The volume of the 
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solution was reduced under vacuum to 50 mL and the residue was flushed through 
a Florisil column containing activated charcoal to furnish 45 (4.70 g, 91 %) as a 
yellow liquid: IR vmu 2919 (m), 1667 (s) em·•. 1H NMR. (CDCl3): 6 7.96 (2H, m), 
7.58-7.42 (3H, m), 5.89 (lfL m), 5.03 (2H, m), 3.01 (2H, ~ J= 7.2), 2.50 (2H, m). 
13C NMR (CDCI1): 6 199.3, 137 .3, 136.9, 133.0, 128.6, 128.0, 115.3, 37.7, 28.1. 
(:i:)-Hydroxybesanoic Acid, 6-Lactone (32) 
0 
According to the procedure of Hernandez and coworkers, 31 a 
~O solution of m-CPBA (6.20 g of 57-86%) in CH2Cl2 (50 mL) was 
~ added to a solution of(±)-2-methylcyclopentanone (1.54 g, 15.7 
32 mmoL) in CH2Cl2 (8 mL) The mixture was stirred at rt for 22 
hours. The mixture was filtered to remove the white precipitate, and the filtrate 
was passed through a Florisil column. The solution was washed with saturated 
NaHC03 (2 x 50 mL). The aqueous layer was then extracted with CH2Cl2 (2 x 50 
mL). The combined organic layers were dried over anhydrous MgS04 and the 
solvent was removed under vacuum. Flash chromatography was performed using 
80% ethyl acetatelhexanes to yield 32 (1.56 g, 87%) as a colorless liquid: 1H 
NMR(CDC13): 6 4.46 (lH, m), 2.59 (lH, m), 2.44 (lH, m), 1.91 (3H, m), 1.53 
(lH, m), 1.38 (3H, d, J = 6.2 Hz). 13C NMR (CDC13): 6 171.9, 76.9, 29.4, 29.1, 
21.6, 18.4. 
106 
Methyl (±)-S-hydroxyhesanoate (33) 
~ According to the method of Hernandez and 
I C~Me 
OH co-oworkers,31 a MeONa/MeOH solutio~ prepared 
33 from sodium (0.13 g, 5.7 mmol) in MeOH (7.7 mL) 
and cooled to -78°C, was cannulated into a solution of32 (4.12 g, 36.1 mmol) in 
MeOH (28 mL), also cooled to -78°C. The reaction was warmed to 0°C and 
stirred at this temperature for 6 hours. Glacial acetic acid (0.39 mL) was added 
and stining was continued for an additional 15 minutes. The solution was washed 
with saturated NaHC03 (2 x 100 mL). The aqueous layers were extracted with 
CH2Cl2 (3 x 100 m.L). The combined organic layers were dried using anhydrous 
MgS04 and the solvent was removed under reduced pressure to yield 33 ( 4.81 g, 
91%) as a colorless liquid. The physical data of 33 was identical to that reported 
by Hernandez and cooworkers.31 'H NMR (CDCI3): 6 3.80 (lH, m), 3.68 (3H, s), 
2.35 (2H~ t, J= 7.1 Hz), 1.72 (2H, m), 1.47 (2H, m)~ 1.19 (3H, d, J= 6.3 Hz). 13C 
NMR(CDCI3): 6 174.4, 67.4, 51.6, 38.6; 33.9, 23.5, 21.2. 
Methyl (±)-5-(tert-butyldimethylsilyl}osybesanoate (34) 
~ According to the procedure of Hernandez and 
I C~Me 
TBSO co-oworkers,31 a solution ofTBS-Cl (1.97 g, 13.1 
34 
mmol) in CH2Cl2 (10 mL) was added dropwise to a 
solution of33 (1.45 g, 9.91 mmol) and imidazole (1.77 g, 26.0 mmol) in CH2Cl2 
(21 mL). The solution was stirred at rt overnight. The solution was washed v-ith 
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saturated NaHC03 (2 x 50 m.L) and brine (25 mL). The organic layer was dried 
over anhydrous MgS04 and the solvent was removed under vacuum. Flash 
chromatography was performed using 5% ethyl acetate/hexanes to provide 34 
(2.58 g, 87%), a colorless liquid. The physical data of34 was identical to that 
reported by Hernandez and co-oworkers.31 1H NMR (CDCL3): ~ 3.79 (lH, m), 3.67 
(3H, s), 2.31 (2H, t, J= 1.3 Hz), 1.75-1.39 (4H, m), 1.12 (3H, ~ J= 6.0 Hz), 0.88 
(9H, s), 0.05 (6H, s). 13C NMR (CDC13): ~ 174.3, 68.4, 51.7, 39.2, 34.3, 26.1, 
23.9, 21.5, 18.3, -4.2, -4.5. 
Methyl 5-oxobexanoate (39) 
0 0 
Compound 39 was produced based on the method of 
II II Corey and Suggs.50 A solution of33 (1.51 g, 10.3 ~OMe 
6 4 1 7 mmol) in CH2Cl2 ( 4 mL) was added to a solution of 
39 
PCC (2.92 g, 13.6 mmol) in CH2Cl2 (18 mL), and the 
mixture was stirred at rt overnight. The solution was decanted from the black 
precipitate, which was then extracted with ethyl ether ( 4 x 50 mL ). The volume 
was reduced to 50 mL under vacuum and the residue was flushed through a 
Florisil column containing activated charcoal. Flash chromatography was 
performed using 50% ethyl acetate/hexanes to yield 39 (1.18 g. 82%) as a 
colorless liquid: 1H NMR(CDC13): o 3.67 (3H, s, H-7), 2.52 (2H, t,J= 7.4 Hz, 
H-2), 2.35 (2H, t, J= 1.5 Hz, H-4), 2.15 (3H, s, H-6), 1.90 (2H, m, H-3). 13C 
NMR(CDC11): 6 208.1, 173.8, 51.7, 42.6, 33.1, 30.1, 19.0. MS mlz (%): 144 (1, 
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M·)~ 112 (11)~ 74 (15), 55 (12), 43 (100). 
4-Metbyl .. 2,3-bis[(trimethylsilyl)oxy) .. J,J..pentadiene (126) 
126 
A solution of2~-dimethyl 
TMSO:q-OTMS dimethylsuccinate (25.6 g, 146 
1'- l' 
1" mmol) in toluene (140 m.L) and 
4 l' 
l" TMS-Cl (86.0 mL, 676 mmol) 
9 
was placed in an addition funneL 
This mixture was slowly added to a stirred and heated suspension ofNa0 (15.03 g~ 
654 mmol) in toluene (355 mL). After the addition was complete, the reaction 
was heated under reflux for 6 hours over the next 2 days. The mixture was 
suction-filtered and the filtrate was concentrated by simple distillation. The 
solution had to be re-distilled, since the product distilled along with toluene. The 
residue was vacuum distilled to yield a colorless liquid. Compounds 126 and 9 
were present in a I :2 ratio (28.8 g). 'H NMR (CDC13): ~ 4.40 (1 H, s, H-1 ), 4.29 
{lH, s, H-1), 1.96 (2H~ s, H-4'), 1.77 (3H, s~ H-t· or H-5), 1.65 (3H, s, H-1· or H-
5), 1.12 (6H, s~ H-1" and H-211), 0.21, 0.20, 0.19, 0.18, 0.17 (-OTMS ofboth 9 and 
126). 
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(3a ·, 7a 1 5,6-bis((trimethylsilyl)oxyj-4,4-dimethyl-1,3-dioxo-2,3,3a,4, 7, 7a-
heubydro-N-Phenyl-1-H-isoindole (128) 
5' 
0 
128 
1" 1" N-Phenylmaleimide 127 (335 mg, 1.93 
OTMS mmol) and a l :2 mixture of 126 and 9 
I : (1.04 g) were dissolved in benzene (25 
OTMS 
mL). The mixture was heated under 
reflux for 4.5 hours and stirred at rt for 3 
days. The volume of the mixture was reduced under vacuum and flash 
chromatography was performed eluting with 15% ethyl acetatelbexanes to provide 
128 (6.0 mg) as a colorless residue: 1H NMR (CDC11): a 7.41 (3H, m, H-3', H-4', 
and H-5'), 7.22 (2H, m, H-2' and H--6'), 3.34 (lH, d~ J= 9.6 ~ H-3a or H-7a), 
3.22 {lH, m, H-3a or H-7a), 2.92 (lH, m, H-7), 2.53 (lH, m, H-7), 1.66 (3H, s, H-
l" or H-2") 1.64 (3H, s, H-1" or H-2"), 0.13 (9H, s, -OTMS), 0.10 (9H, s, -
OTMS). MS mlz (%): 342 (14), 341 (M'"-OTMS, 45), 267 (20), 195 (11), 194 
(50), 179 (38 ), 147 (20), 122 (17), 119 (12), 105 (20), 95 (20), 93 (14), 91 (22), 
79 (11), 77 (29), 75 (47), 73 (100), 65 (13), 51 (11), 45 (18), 43 (50), 41 (13), 39 
(15), 28 (19). 
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Ethyl 0-(mesitylenesulfonyl)-acetohydroxamate (71) 
Compound 7l and the intermediate 71 
0 
II .. / were prepared according to the method 
s-o-N~ A ~ ofTamuraandco-workers.34 Mesitylene 
71 
sulfonyl chloride 70 (13.5 g, 61.8 mmol) 
was added to a solution of ethyl acetohydroam&te 69 (5.11 g, 49.6 mmol) and 
triethylamine (5.58 g, 55.1 mmol) in DMF (13 mL) in small portions over a period 
of25 minutes with stirring and with cooling in an ice bath. Triethylamine (0.45 
mL) was added to the mixture to keep the reaction mixture basic. Stirring was 
continued for an additional 20 minutes at 5-1 0°C, and then the mixture was 
poured into ice/water (30 mL). A white solid was collected and washed 
thoroughly with H20 (75 mL). The solid was dissolved in diethyl ether (SO m.L) 
and dried over anhydrous MgS04• The diethyl ether was removed under reduced 
pressure to yield a solid, which was then dissolved in petroleum ether with slight 
warming. The solution was filtered, and the filtrate was chilled in a dry ice 
acetone bath. The precipitate was collected and dried under vacuum to yield 71 
(10.2 g, 76%) as a beige solid: 1H NMR (CDC13): 6 6.97 (2H, s), 3.09 (2H, q, J= 
7.2 Hz}. 2.65 (6H, s), 2.32 (3H, s), 2.04 (3H, s), 1.19 (3H, t, J= 7.2 Hz). 13C NMR. 
(CDCl3): 6 169.4, 143.5, 140.9, 131.7, 130.5, 63.8, 23.0, 21.3, 15.1, 14.8. 
111 
0-Mesitylenesulfonylhydroxylamine (72) 
To a solution of71 (1.66 g, 6.07 mmol) in dioxane 
0 
II (4.6 mL)~ 70% perchloric acid (0.6 mL) was added 
s-o-NHt 
II 
0 dropwise with stirring at 0°C. Stirring was 
72 
continued for an additional 30 minutes. The 
mixture was poured into ice/water (25 mL) to yield a white solid, which was 
collected. washed with cold water (SO mL), then with cold petroleum ether (50 
mL ), and dried under vacuum to yield 72 ( 1.02 g, 78%) as a white solid: 1 H NMR 
(CDC13): 6 7.00 (2H. s), 5.19 (2H, bs), 2.67 (6H, s), 2.33 (3H, s). 13C NMR 
(CDCI3}: 6 144.0, 141.1, 131.9. 129.2 .. 120.5, 22.9, 21.3. 
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Appendix 1: X-ray structures 
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